EPrf Alastair Burt
Office of Health
College of Health
Emeritus Professor Alastair Burt BSc (Hons), MBChB, MD (Hons), FRCPath, FRCP, FRCPA, FRSB, FAcadMEd, FAHMSAlastair Burt was born in Dunfermline, Scotland and is a graduate of the University of Glasgow where he obtained a BSc in Pathology with First Class Honours in 1979, MBChB with Commendation in 1981 and MD with Honours and the Bellahouston Medal in 1991. Upon graduation, he became Junior House Officer in General Medicine with Professor Sir Abraham Goldberg and Junior House Officer in Surgery with Professor Sir David Carter. He subsequently took up training in surgical pathology under the tutelage of Professor Sir Roddy MacSween. During this time, he developed expertise in diagnostic pathology of the liver and a keen interest in the pathogenesis of liver disease and in particular mechanisms of liver fibrosis. In 1985-86 he was a Peel Trust Fellow in the Lab for Cell Biology and Histology at Free University of Brussels under the direction of Professor Eddie Wisse. On return to the UK and completion of his postgraduate training in surgical pathology he moved to the University of Newcastle upon Tyne to become Senior Lecturer in Pathology and Honorary Consultant Histopathologist. He was promoted to a personal Chair in Hepatopathology in 1995 and then the established Chair of Pathology in 1998. He became Dean of Clinical Medicine at the University of Newcastle upon Tyne in 2005. He moved to South Australia in January 2013 to take up the post of Dean of Medicine and Head of the School of Medicine. In August 2014, he became acting Executive Dean of the Faculty of Health and Medical Sciences and was appointed to the substantive role in December 2014. He continued to maintain an active research interest in liver disease and has published extensively in high quality peer-reviewed journals including Nature, Nature Medicine, Nature Communications, Lancet, N Engl J Med, Gastroenterology, Hepatology. He has an H index of 72 and over 20000 citations. He has secured over $8m in external grants and has supervised 16 HDR students to completion. He is Editor in Chief of the principal international text book in his field, MacSween’s Pathology of the Liver, now into its 7th edition. In addition, in 2018 he completed seven years as Editor in Chief of the peer reviewed journal, Histopathology. He was elected as a Fellow of the Australian Academy of Health and Medical Sciences in 2015. As Executive Dean, he successfully led a number of major changes which include restructure of the Faculty, implementation of the most comprehensive Faculty-level professional services reform program in the institution, ‘reimagining’ of the Bachelor of Health Sciences and Psychological Sciences programs and the development of a new Bachelor/MD program in Medicine to achieve AQF level 9 status. He chaired the key governance groups for the development of the $240m Adelaide Health and Medical Sciences building which was officially opened in February 2017. He was a member of the Board of SAHMRI, the Executive of the SA Health Research and Translation Centre and Adelaide BioMed City Partners. He developed strong partnerships with key stakeholders in the health sector in particular SA Health and its networks and chaired the SA Clinical Training Council. Emeritus Professor Burt retired from the role of Executive Dean on 1 March 2019 and now resides in the UK where he is Professor of Precision and Molecular Pathology at Newcastle University and Director of ADB Health Solutions. He is also Honorary Consultant Histopathologist in the Newcastle upon Tyne Hospitals NHS Foundation Trust and Director of NovoPath, the Newcastle MRC Node for Molecular Pathology and institutional lead for Precision Medicine, Genomics and Informatics. He is co-lead for one of the strand of Informatics for Precision Care the current Newcastle bid for NIHR BRC4 funding. He was recently awarded the Presidents's Medal from the British Division of the International Academy of Pathology. For the past two years he has (remotely) provided the liver biopsy service for Bart's and the London Hospital/QUML.
Research Interests
Professor Burt has a long standing interest in the pathogenesis of liver fibrosis. This is an important part of progressive liver disease and an essential component for the development of cirrhosis. He played a pivotal role in establishing the principal cell type involved in fibrogenesis is the hepatic stellate cell and was the first to characterise their cell kinetics in the response to injury establishing that there is not only proliferation of these cells in response to necrosis but a phenotypic modulation to myofibroblast-like cell. He was among the first to utilise isolated cell preparations of stellate cells to characterise in vitro properties such as collagen production and to examine the effects of cytokines responsible for activating these cells. In parallel with basic studies of fibrogenesis he has been involved in applied studies of surrogate markers of fibrogenesis and this has led to the development of algorithms of serum markers that represent an effective means of monitoring fibrosis in individual patients. He has attracted grant funding of over $8.5 million including awards from the MRC, Wellcome Trust and NIH. He played a key role on an FP7 EU grant on fatty liver disease leading a consortium tasked with redefining steatohepatitis for diagnostic epidemiological purposes. He has been editor or co-editor of eight textbooks, 22 book chapters and over 190 scientific publications. He has been supervisor or co-supervisor for 17 HDR students. He was a member of one of the panels of the UK RAE 2008 and was appointed to the REF 2014 exercise before moving to Australia.
He continues to be clinically active and has an appointment as a senior consultant anatomical pathologist with SA Pathology with responsibility for gastrointestinal and liver surgical pathologies. He has full registration with AHPRA. He is one of the senior members of the International Hepatopathology Group (Gnomes) an organisation which has been in existence since 1967 and which has been responsible for major classifications and diagnostic approaches to liver disease.
| Date | Position | Institution name |
|---|---|---|
| 2019 - ongoing | Professor of Precision and Molecular Pathology | Newcsatle University |
| 2019 - ongoing | Emeritus Professor | University of Adelaide |
| 2014 - 2019 | Executive Dean | University of Adelaide |
| 2014 - 2014 | Acting Executive Dean | University of Adelaide |
| 2013 - 2014 | Dean of Medicine and Head of School | University of Adelaide |
| 1998 - 2012 | Established Chair of Pathology and Dean of Clinical Medicine (from 2005) | University of Newcastle upon Tyne |
| 1995 - 1998 | Personal Professorship in Hepatopathology | University of Newcastle upon Tyne |
| 1989 - 1995 | Senior Lecturer in Pathology | University of Newcastle upon Tyne, Royal Victoria Infirmary |
| 1986 - 1989 | Registrar and Senior Registrar in Pathology | Western Infirmary |
| 1986 - 1986 | Honorary Clinical Teacher | University of Glasgow |
| 1985 - 1986 | Peel Travelling Research Fellow | Free University of Brussels |
| 1982 - 1985 | Senior House Officer/Registrar in Pathology | Western Infirmary |
| 1982 - 1982 | Junior House Officer in General Surgery | Royal Infirmary |
| 1981 - 1982 | Junior House Officer in General Medicine | Western Infirmary |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2014 | Fellowship | Royal College of Pathologists of Australasia | - | - | - |
| 2009 | Fellowship | Royal College of Physicians | - | United Kingdom | - |
| 2009 | Fellowship | Fellowship of the Royal College of Physicians (London) | - | - | - |
| 1997 | Fellowship | Fellowship of the Royal College of Pathologists | - | - | - |
| 1997 | Fellowship | Royal College of Pathologists | - | - | - |
| 1996 | Fellowship | Institute of Biologists | - | - | - |
| 1996 | Fellowship | Fellow of the Institute of Biologists (now Fellow of the Royal Society of Biologists) | - | - | - |
| 1993 | Award | Canterbury Medical Foundation Research Award | University of Otago | - | - |
| 1993 | Achievement | CL Oakley Lectureship | Pathological Society of Great Britain and Ireland | - | - |
| 1992 | Award | Bellahouston Medal | University of Glasgow | - | - |
| 1981 | Award | Agnes Cameron and Mary Margaret Isabel Ure Prize | - | - | - |
| 1981 | Award | John W Weir Prize | - | - | - |
| 1980 | Award | Glasgow University Medical Chirurgical Society Calman Trophy | - | - | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 1991 | University of Glasgow | United Kingdom | M.D. with Honours and Medal |
| 1981 | University of Glasgow | United Kingdom | M.B. Ch.B. with Commendation |
| 1979 | University of Glasgow | United Kingdom | B.Sc. in Pathology with First Class Honours |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 2015 | Fellowship of the Australian Academy of Health and Medical Sciences | Australian Academy of Health and Medical Sciences | - |
| 2015 | Fellowship of Academy of Medical Educators | Academy of Medical Educators | - |
| 2014 | Fellowship of the Royal College of Pathologists of Australasia | Royal College of Pathologists of Australasia | - |
| 2009 | Fellowship of the Royal College of Physicians | Royal College of Physicians | - |
| 2007 | Foundation Member | Academy Medical Educators | - |
| 1997 | Fellowship of the Royal College of Pathologists | Royal College of Pathologists | - |
| 1996 | Fellowship of the Royal Society of Biologists | Royal Society of Biologists | - |
| — | Membership | Royal College of Pathologists | - |
| — | Membership | Institute of Biologists | - |
| Year | Citation |
|---|---|
| 2026 | Allende, D., & Burt, A. D. (2026). Head to head: should portal inflammation be part of grading necroinflammatory activity in metabolic dysfunction-associated steatotic liver disease?. Histopathology, 12 pages. |
| 2025 | Chan, C. D., Brookes, M. J., Pringle, T. A., Pal, R., Tanwani, R., Burt, A. D., . . . Rankin, K. S. (2025). Investigating the mechanisms of indocyanine green tumour uptake in sarcoma cell lines and ex vivo human tissue. Journal of Pathology, 267(3), 315-328. Scopus1 WoS1 |
| 2025 | Lackner, C., Gouw, A. S. H., Avancini Ferreira Alves, V., Arola, J., Bedossa, P., Behling, C., . . . Tiniakos, D. G. (2025). Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials. Journal of Hepatology, S0168-8278(25)02501-2. Scopus1 |
| 2025 | Burt, A. D., & Tiniakos, D. G. (2025). The changing landscape of liver transplantation and the role of histopathology. Histopathology, 86(4), 514-515. |
| 2025 | Burt, A. D., Gouw, A. S. H., Callea, F., Clouston, A. D., Dienes, H. P., Goodman, Z. D., . . . Zen, Y. (2025). Making Sense of ‘Porto-Sinusoidal Vascular Disorder’: What Does It Mean for the Pathologist and the Patient?. Liver International, 45(1), 3 pages. Scopus3 WoS3 Europe PMC1 |
| 2024 | Armandi, A., Sanavia, T., Younes, R., Caviglia, G. P., Rosso, C., Govaere, O., . . . Bugianesi, E. (2024). Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut, 73(5), 825-834. Scopus34 WoS28 Europe PMC23 |
| 2024 | Clouston, A. D., Gouw, A. S. H., Tiniakos, D., Bedossa, P., Brunt, E. M., Callea, F., . . . Burt, A. D. (2024). Severe acute liver disease in adults: Contemporary role of histopathology. Histopathology, 85(4), 549-561. Scopus6 WoS6 Europe PMC6 |
| 2024 | Soon, G. S. T., Callea, F., Burt, A. D., Cook, S., Terracciano, L., Ercan, C., . . . Torbenson, M. (2024). Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma. Human Pathology, 149, 55-65. Scopus2 WoS3 Europe PMC1 |
| 2024 | Vacca, M., Kamzolas, I., Harder, L. M., Oakley, F., Trautwein, C., Hatting, M., . . . Davies, S. (2024). An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature Metabolism, 6(6), 1178-1196. Scopus122 WoS119 Europe PMC120 |
| 2024 | Iyer, J. S., Juyal, D., Le, Q., Shanis, Z., Pokkalla, H., Pouryahya, M., . . . Beck, A. H. (2024). AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases. Nature Medicine, 30(10), 2914-2923. Scopus31 WoS26 Europe PMC28 |
| 2024 | McNeil, C., Wong, P. F., Sridhar, N., Wang, Y., Santori, C., Wu, C. H., . . . Cimermancic, P. (2024). An End-to-End Platform for Digital Pathology Using Hyperspectral Autofluorescence Microscopy and Deep Learning-Based Virtual Histology. Modern Pathology, 37(2), 12 pages. Scopus15 WoS12 Europe PMC8 |
| 2024 | McGenity, C., Randell, R., Bellamy, C., Burt, A., Cratchley, A., Goldin, R., . . . Treanor, D. (2024). Survey of liver pathologists to assess attitudes towards digital pathology and artificial intelligence. Journal of Clinical Pathology, 77(1), 27-33. Scopus7 WoS7 Europe PMC4 |
| 2023 | Anstee, Q. M., Darlay, R., Cockell, S., Meroni, M., Govaere, O., Tiniakos, D., . . . Daly, A. K. (2023). Corrigendum to: “Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆” [J Hepatol (2020) 505–515, (S0168827820302130), (10.1016/j.jhep.2020.04.003)]. Journal of Hepatology, 78(5), 1085-1086. Scopus2 WoS4 Europe PMC1 |
| 2023 | Burt, A. D. (2023). Augmented liver pathology: artificial intelligence and the assessment of hepatocellular neoplasms. Histopathology, 83(4), 509-511. Scopus2 WoS2 Europe PMC2 |
| 2023 | Mózes, F. E., Lee, J. A., Vali, Y., Alzoubi, O., Staufer, K., Trauner, M., . . . Davies, S. (2023). Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis. Lancet Gastroenterology and Hepatology, 8(8), 704-713. Scopus154 Europe PMC125 |
| 2023 | Iyer, J. S., Pokkalla, H., Biddle-Snead, C., Carrasco-Zevallos, O., Lin, M., Shanis, Z., . . . Wapinski, I. (2023). AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trials.. medRxiv. |
| 2022 | Geh, D., Watson, R., Sen, G., French, J. J., Hammond, J., Turner, P., . . . Reeves, H. L. (2022). COVID-19 and liver cancer: Lost patients and larger tumours. BMJ Open Gastroenterology, 9(1), 9 pages. Scopus21 WoS24 Europe PMC24 |
| 2022 | Zaki, M. Y. W., Alhasan, S. F., Shukla, R., McCain, M., Laszczewska, M., Geh, D., . . . Reeves, H. L. (2022). Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?. Liver Cancer, 11(6), 540-557. Scopus12 WoS12 Europe PMC10 |
| 2022 | Kobayashi, H., Gieniec, K. A., Lannagan, T. R., Wang, T., Asai, N., Mizutani, Y., . . . Worthley, D. L. (2022). The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis. Gastroenterology, 162(3), 890-906. Scopus149 WoS157 Europe PMC149 |
| 2022 | Younes, R., Govaere, O., Petta, S., Miele, L., Tiniakos, D., Burt, A., . . . Bugianesi, E. (2022). Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?. Gut, 71(2), 382-390. Scopus172 WoS165 Europe PMC146 |
| 2021 | Anstee, Q. M., Darlay, R., Cockell, S., Meroni, M., Govaere, O., Tiniakos, D., . . . EPoS Consortium Investigators. (2021). Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515).. Journal of hepatology, 74(5), 1274-1275. Scopus3 WoS6 Europe PMC7 |
| 2021 | Eldafashi, N., Darlay, R., Shukla, R., McCain, M. V., Watson, R., Liu, Y. L., . . . Reeves, H. L. (2021). A pdcd1 role in the genetic predisposition to nafld-hcc?. Cancers, 13(6), 1-17. Scopus30 WoS29 Europe PMC26 |
| 2021 | Younes, R., Caviglia, G. P., Govaere, O., Rosso, C., Armandi, A., Sanavia, T., . . . Bugianesi, E. (2021). Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.. Journal of hepatology, 75(4), 786-794. Scopus161 WoS149 Europe PMC131 |
| 2021 | Connoley, D., Patel, P. J., Hogan, B., Tanwar, S., Rhodes, F., Parkes, J., . . . Rosenberg, W. (2021). The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study. BMC Gastroenterology, 21(1), 11 pages. Scopus17 WoS19 Europe PMC16 |
| 2021 | Torbenson, M., Desmet, V., Denk, H., Callea, F., Burt, A. D., Hübscher, S. G., . . . Tiniakos, D. (2021). Fifty years of impact on liver pathology: a history of the Gnomes. Virchows Archiv, 478(2), 191-200. Scopus2 WoS3 Europe PMC1 |
| 2021 | Ireland, P. J., Hardy, T., Burt, A. D., & Donnelly, M. C. (2021). Drug-induced hepatocellular injury due to herbal supplement ashwagandha. Journal of the Royal College of Physicians of Edinburgh, 51(4), 363-365. Scopus19 WoS19 Europe PMC14 |
| 2021 | Kobayashi, H., Gieniec, K. A., Ng, J. Q., Goyne, J., Lannagan, T. R. M., Thomas, E. M., . . . Woods, S. L. (2021). Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma. Journal of Visualized Experiments, 2021(175), e62630-1-e62630-21. Scopus2 WoS2 Europe PMC3 |
| 2020 | Connoley, D., Patel, P., Hogan, B., Tanwar, S., Rhodes, F., Parkes, J., . . . Rosenberg, W. (2020). The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: A cohort study.. |
| 2020 | Zorron Cheng Tao Pu, L., Yamamura, T., Nakamura, M., Koay, D. S. C., Ovenden, A., Edwards, S., . . . Singh, R. (2020). Comparison of different virtual chromoendoscopy classification systems for the characterization of colorectal lesions. JGH Open, 4(5), 818-826. Scopus10 WoS8 Europe PMC6 |
| 2020 | Zorron Cheng Tao Pu, L., Singh, G., Rana, K., Nakamura, M., Yamamura, T., Krishnamurthi, S., . . . Singh, R. (2020). Polyp Detection Rate as a Surrogate for Adenoma and Sessile Serrated Adenoma/Polyp Detection Rates.. Gastrointestinal tumors, 7(3), 74-82. WoS10 Europe PMC9 |
| 2020 | Hardy, T., Wonders, K., Younes, R., Aithal, G. P., Aller, R., Allison, M., . . . Anstee, Q. M. (2020). The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. Contemporary Clinical Trials, 98, 11 pages. Scopus105 WoS107 Europe PMC95 |
| 2020 | Kobayashi, H., Gieniec, K. A., Wright, J. A., Wang, T., Asai, N., Mizutani, Y., . . . Woods, S. L. (2020). The Balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis. Gastroenterology, 160(4), 1224-1239. Scopus124 WoS121 Europe PMC123 |
| 2020 | Younes, R., Govaere, O., Petta, S., Miele, L., Tiniakos, D., Burt, A., . . . Bugianesi, E. (2020). Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology, 115(8), 1289-1292. Scopus16 WoS13 Europe PMC11 |
| 2020 | Zorron Cheng Tao Pu, L., Rana, K., Singh, G., Nakamura, M., Yamamura, T., Koay, D. S. C., . . . Singh, R. (2020). Different factors are associated with conventional adenoma and serrated colorectal Neoplasia. Nagoya Journal of Medical Science, 82(2), 335-343. Scopus7 WoS6 Europe PMC3 |
| 2020 | Zorron Cheng Tao Pu, L., Yamamoto, K., Honda, T., Nakamura, M., Yamamura, T., Hattori, S., . . . Fujishiro, M. (2020). Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon. Journal of Gastroenterology and Hepatology Australia, 35(3), 433-437. Scopus51 WoS42 Europe PMC37 |
| 2020 | Zorron Cheng Tao Pu, L., Yamamura, T., Nakamura, M., Esaki, M., Kaosombatwattana, U., Rodriguez, M. R., . . . Fujishiro, M. (2020). Learning curve for mastery of colorectal endoscopic submucosal dissection: Perspectives from a large Japanese cohort. JGH Open, 4(4), 611-616. Scopus11 WoS12 Europe PMC9 |
| 2020 | Cheng Tao Pu, L. Z., Maicas, G., Tian, Y., Yamamura, T., Nakamura, M., Suzuki, H., . . . Singh, R. (2020). Computer-aided diagnosis for characterisation of colorectal lesions: a comprehensive software including serrated lesions. Gastrointestinal Endoscopy, 92(4), 891-899. Scopus44 WoS40 Europe PMC23 |
| 2020 | Carneiro, G., Zorron Cheng Tao Pu, L., Singh, R., & Burt, A. (2020). Deep learning uncertainty and confidence calibration for the five-class polyp classification from colonoscopy. Medical Image Analysis, 62, 1-13. Scopus60 WoS54 Europe PMC24 |
| 2020 | Anstee, Q. M., Darlay, R., Cockell, S., Meroni, M., Govaere, O., Tiniakos, D., . . . EPoS Consortium Investigators. (2020). Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort.. Journal of hepatology, 73(3), 505-515. Scopus400 WoS373 Europe PMC362 |
| 2019 | Houghton, D., Zalewski, P., Hallsworth, K., Cassidy, S., Thoma, C., Avery, L., . . . Trenell, M. I. (2019). The degree of hepatic steatosis associates with impaired cardiac and autonomic function. Journal of Hepatology, 70(6), 1203-1213. Scopus67 WoS60 Europe PMC51 |
| 2019 | Brial, F., Le Lay, A., Hedjazi, L., Tsang, T., Fearnside, J. F., Otto, G. W., . . . Gauguier, D. (2019). Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment. Scientific Reports, 9(1), 10 pages. Scopus10 WoS9 Europe PMC9 |
| 2019 | Zorron Cheng Tao Pu, L., Lu, K., Ovenden, A., Rana, K., Singh, G., Krishnamurthi, S., . . . Singh, R. (2019). Effect of time of day and specialty on polyp detection rates in Australia. Journal of Gastroenterology and Hepatology, 34(5), 899-906. Scopus12 WoS16 Europe PMC13 |
| 2019 | Kobayashi, H., Enomoto, A., Woods, S. L., Burt, A. D., Takahashi, M., & Worthley, D. L. (2019). Cancer-associated fibroblasts in gastrointestinal cancer. Nature Reviews Gastroenterology and Hepatology, 16(5), 282-295. Scopus469 WoS458 Europe PMC429 |
| 2019 | Zorron Cheng Tao Pu, L., Chiam, K. H., Yamamura, T., Nakamura, M., Berzin, T. M., Mir, F. F., . . . Singh, R. (2019). Narrow-band imaging for scar classification: from conception to multicenter validation.. Gastrointestinal endoscopy, 91(5), 14 pages. Scopus11 WoS8 Europe PMC9 |
| 2018 | Burt, A. D. (2018). A further change of the guard. Histopathology, 73(6), 876-877. |
| 2018 | Shalapour, S., Lin, X. J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., . . . Karin, M. (2018). Erratum to: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity (Nature, (2017), 551, 7680, (340-345), 10.1038/nature24302). Nature, 561(7721), E1. Scopus6 WoS6 Europe PMC5 |
| 2018 | Burt, A. D., Alves, V., Bedossa, P., Clouston, A., Guido, M., Hübscher, S., . . . Ellis, D. W. (2018). Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 73(3), 369-385. Scopus41 WoS40 Europe PMC36 |
| 2017 | Shalapour, S., Lin, X. -J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., . . . Karin, M. (2017). Inflammation-induced IgA⁺ cells dismantle anti-liver cancer immunity. Nature, 551(7680), 340-345. Scopus480 WoS452 Europe PMC442 |
| 2017 | Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C., Lahat, A., . . . Jurk, D. (2017). Cellular senescence drives age-dependent hepatic steatosis. Nature Communications, 8(1), 15691-1-15691-12. Scopus852 WoS806 Europe PMC789 |
| 2017 | Burt, A. D. (2017). Annual review issue: surgical pathology of 21st century medicine. Histopathology, 70(1), 3. |
| 2017 | McPherson, S., Hardy, T., Dufour, J., Petta, S., Romero-Gomez, M., Allison, M., . . . Anstee, Q. (2017). Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. American Journal of Gastroenterology, 112(5), 740-751. Scopus746 WoS710 Europe PMC627 |
| 2017 | Shalapour, S., Lin, X. -J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., . . . Karin, M. (2017). Erratum: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.. Nature, 552(7685), 430. WoS6 Europe PMC4 |
| 2017 | Burt, A. D. (2017). From this month's. HISTOPATHOLOGY, 71(1), 2 pages. |
| 2017 | Lackner, C., Bataller, R., Burt, A., Miquel, R., Schuppan, D., Tiniakos, D., & Trauner, M. (2017). Fibrosis evaluation by transient elastography in alcoholic liver disease: is the histological scoring system impacting cutoff values?. Hepatology, 65(5), 1758-1761. Scopus5 WoS4 Europe PMC4 |
| 2017 | McPherson, S., Wilkinson, N., Tiniakos, D., Wilkinson, J., Burt, A., McColl, E., . . . Day, C. (2017). A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis. PLoS ONE, 12(4), e0175717-1-e0175717-17. Scopus54 WoS45 Europe PMC41 |
| 2017 | Houghton, D., Thoma, C., Hallsworth, K., Cassidy, S., Hardy, T., Burt, A., . . . Trenell, M. (2017). Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology, 15(1), 96-102.e3. Scopus187 WoS159 Europe PMC138 |
| 2016 | Alhasan, S., Haugk, B., Ogle, L., Beale, G., Long, A., Burt, A., . . . Reeves, H. (2016). Sulfatase-2: A prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma. British Journal of Cancer, 115(7), 797-804. Scopus17 WoS19 Europe PMC16 |
| 2016 | Munteanu, M., Tiniakos, D., Anstee, Q., Charlotte, F., Marchesini, G., Bugianesi, E., . . . Mercadier, A. (2016). Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Alimentary Pharmacology and Therapeutics, 44(8), 877-889. Scopus88 WoS71 Europe PMC70 |
| 2016 | Singh, R., Tao Pu, L. Z. C., Koay, D., & Burt, A. (2016). Sessile serrated adenoma/polyps: Where are we at in 2016?. World Journal of Gastroenterology, 22(34), 7754-7759. Scopus34 WoS27 Europe PMC24 |
| 2016 | Liew, V. Y., Chapman, M. J., Nguyen, N. Q., Cousins, C. E., Plummer, M. P., Chapple, L. A. S., . . . Deane, A. M. (2016). A prospective observational study of the effect of critical illness on ultrastructural and microscopic morphology of duodenal mucosa. Critical Care and Resuscitation, 18(2), 102-108. Scopus6 WoS6 Europe PMC7 |
| 2016 | Dunn, L., Burt, A., Hayes, N., & Griffin, S. (2016). Columnar metaplasia in the esophageal remnant after esophagectomy: a common occurrence and a valuable insight into the development of Barrett esophagus. Annals of Surgery, 264(6), 1016-1021. Scopus16 WoS10 Europe PMC10 |
| 2016 | Burt, A., & Whelan, E. (2016). Professor Sir Roddy MacSween - Obituary. HISTOPATHOLOGY, 68(6), 773-775. |
| 2016 | Shay, J. W., Homma, N., Zhou, R., Naseer, M. I., Chaudhary, A. G., Al-Qahtani, M., . . . Alqahtani, M. H. (2016). Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015.. BMC genomics, 17 Suppl 6(Suppl 6), 487. Europe PMC17 |
| 2016 | Burt, A. D. (2016). From This Month's Histopathology. Histopathology, 68(4), 473-474. |
| 2016 | Shi, Z., Chen, W., Taylor, A., & Burt, A. (2016). Elevated transaminase levels among overweight adolescents in eastern China. Acta Paediatrica, International Journal of Paediatrics, 105(12), e593-e599. |
| 2016 | Burt, A. D. (2016). From this month’s Histopathology. Histopathology, 68(2), 171-172. |
| 2016 | Burt, A. D. (2016). From this month’s Histopathology. Histopathology, 68(5), 627-628. |
| 2015 | McPherson, S., Hardy, T., Henderson, E., Burt, A., Day, C., & Anstee, Q. (2015). Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. Journal of Hepatology, 62(5), 1148-1155. Scopus905 WoS831 Europe PMC751 |
| 2015 | Burt, A., Lackner, C., & Tiniakos, D. (2015). Diagnosis and assessment of NAFLD: definitions and histopathological classification. Seminars in Liver Disease, 35(3), 207-220. Scopus125 WoS111 Europe PMC96 |
| 2015 | Cornell, L., Munck, J., Alsinet, C., Villanueva, A., Ogle, L., Willoughby, C., . . . Reeves, H. (2015). DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival. Clinical Cancer Research, 21(4), 925-933. Scopus76 WoS74 Europe PMC68 |
| 2015 | Bedossa, P., Burt, A. D., Brunt, E., Callea, F., Clouston, A. D., Dienes, H. P., . . . Wanless, I. R. (2015). Well-differentiated hepatocellular neoplasm of uncertain malignant potential - Reply. Human Pathology, 46(4), 635-636. Scopus5 WoS6 Europe PMC6 |
| 2014 | Bedossa, P., & FLIP Pathology Consortium. (2014). Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology, 60(2), 565-575. Scopus559 WoS491 Europe PMC432 |
| 2014 | Probert, P., Ebrahimkhani, M., Oakley, F., Mann, J., Burt, A., Mann, D., & Wright, M. (2014). A reversible model for periportal fibrosis and a refined alternative to bile duct ligation. Toxicology Research, 3(2), 98-109. Scopus11 WoS11 |
| 2014 | McPherson, S., Henderson, E., Burt, A., Day, C., & Anstee, Q. (2014). Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 60(5), 1055-1062. Scopus104 WoS95 Europe PMC88 |
| 2014 | Brunt, E., Gouw, A., Hubscher, S., Tiniakos, D., Bedossa, P., Burt, A., . . . Wanless, I. (2014). Pathology of the liver sinusoids. Histopathology, 64(7), 907-920. Scopus73 WoS58 Europe PMC52 |
| 2014 | Liu, Y., Reeves, H., Burt, A., Tiniakos, D., McPherson, S., Leathart, J., . . . Anstee, Q. (2014). TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nature Communications, 5(1), 4309-1-4309-6. Scopus557 WoS492 Europe PMC454 |
| 2014 | Liu, Y., Patman, G., Leathart, J., Piguet, A., Burt, A., Dufour, J., . . . Anstee, Q. (2014). Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Journal of Hepatology, 61(1), 75-81. Scopus496 WoS448 Europe PMC394 |
| 2014 | Masson, S., Emmerson, I., Henderson, E., Fletcher, E., Burt, A., Day, C., & Stewart, S. (2014). Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease. Liver International, 34(2), 235-242. Scopus42 WoS33 Europe PMC29 |
| 2013 | Elsharkawy, A., Schwab, U., McCarron, B., Burt, A., Daly, A., Hudson, M., & Masson, S. (2013). Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser. Journal of Clinical Virology, 58(1), 331-333. Scopus16 WoS11 Europe PMC11 |
| 2013 | Thompson, E., Burt, A., Barker, C., Kirby, J., & Brain, J. (2013). Development of a robust protocol for gene expression analysis using formalin-fixed, paraffin-embedded liver transplant biopsy specimens. Journal of Clinical Pathology, 66(9), 815-818. Scopus2 WoS3 Europe PMC2 |
| 2013 | Brain, J., Robertson, H., Thompson, E., Humphreys, E., Gardner, A., Booth, T., . . . Kirby, J. (2013). Biliary epithelial senescence and plasticity in acute cellular rejection. American Journal of Transplantation, 13(7), 1688-1702. Scopus35 WoS30 Europe PMC23 |
| 2013 | Bedossa, P., Burt, A., Brunt, E., Callea, F., Clouston, A., Dienes, H., . . . Wanless, I. (2013). Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category. Human Pathology, 45(3), 658-659. Scopus53 WoS52 Europe PMC43 |
| 2013 | Robinson, S., Mann, J., Vasilaki, A., Mathers, J., Burt, A., Oakley, F., . . . Mann, D. (2013). Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. Journal of Hepatology, 59(2), 318-326. Scopus114 WoS96 Europe PMC84 |
| 2013 | McPherson, S., Anstee, Q., Henderson, E., Day, C., & Burt, A. (2013). Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?. European Journal of Gastroenterology & Hepatology, 25(6), 652-658. Scopus81 WoS76 Europe PMC64 |
| 2013 | Hardy, T., Wells, C., Kendrick, S., Hudson, M., Day, C., Burt, A., . . . Stewart, S. (2013). White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers. BMC Gastroenterology, 13(1), 55-1-55-5. Scopus36 WoS30 Europe PMC24 |
| 2013 | Fairhall, E., Wallace, K., White, S., Huang, G., Shaw, J., Wright, S., . . . Wright, M. (2013). Adult human exocrine pancreas differentiation to hepatocytes - potential source of a human hepatocyte progenitor for use in toxicology research. Toxicology Research, 2(1), 80-87. Scopus10 WoS10 |
| 2013 | Moles, A., Sanchez, A., Banks, P., Murphy, L., Luli, S., Borthwick, L., . . . Oakley, F. (2013). Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response. Hepatology, 57(2), 817-828. Scopus37 WoS37 Europe PMC28 |
| 2013 | Lastowska, M., Al-Afghani, H., Al-Balool, H., Sheth, H., Mercer, E., Coxhead, J., . . . Jackson, M. (2013). Identification of a neuronal transcription factor network involved in medulloblastoma development. Acta neuropathologica communications, 1(1), 35-1-35-16. Scopus40 WoS40 Europe PMC38 |
| 2013 | Burt, A. (2013). Roger Cotton Histopathology Prize 2012. Histopathology, 62(7), 975. |
| 2012 | Elsharkawy, A., McPherson, S., Masson, S., Burt, A., Dawson, R., & Hudson, M. (2012). Cholestase bei jungen Mannern nach Anabolika-Einnahme [Cholestasis secondary to anabolic steroid use in young men]. Praxis, 101(10), 661-664. |
| 2012 | Burt, A. D. (2012). Editorial. Histopathology, 60(6), 853. |
| 2012 | Burt, A. (2012). Roger Cotton Histopathology prize 2011. Histopathology, 61(5), 759. |
| 2012 | Mathurin, P., Hadengue, A., Bataller, R., Addolorato, G., Burra, P., Burt, A., . . . Nevens, F. (2012). EASL clinical practical guidelines: management of alcoholic liver disease. Journal of Hepatology, 57(2), 399-420. Scopus632 WoS531 Europe PMC433 |
| 2012 | Burt, A. D. (2012). Changing of the guard. Histopathology, 60(2), 233-235. Scopus2 WoS2 Europe PMC2 |
| 2012 | Simeon-Dubach, D., Burt, A. D., & Hall, P. A. (2012). Quality really matters: The need to improve specimen quality in biomedical research. Journal of Pathology, 228(4), 431-433. Scopus46 WoS38 Europe PMC37 |
| 2012 | Zeybel, M., Hardy, T., Wong, Y. K., Mathers, J. C., Fox, C. R., Gackowska, A., . . . Mann, J. (2012). Erratum: Multigenerational epigenetic adaptation of the hepatic woundhealing response (Nature Medicine (2012) 18 (1369-1377)). Nature Medicine, 18(10), 1592. Scopus6 WoS5 |
| 2012 | Tunwar, S., Trembling, P., Guha, I., Parkes, J., Kaye, P., Burt, A., . . . Rosenberg, W. (2012). Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Hepatology, 57(1), 103-111. Scopus106 WoS100 Europe PMC79 |
| 2012 | Robinson, S., Wilson, C., Burt, A., Manas, D., & White, S. (2012). Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Annals of Surgical Oncology, 19(13), 4287-4299. Scopus194 WoS173 Europe PMC137 |
| 2012 | Zeybel, M., Hardy, T., Wong, Y., Mathers, J., Fox, C., Gackowska, A., . . . Mann, J. (2012). Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nature Medicine, 18(9), 1369-1377. Scopus242 WoS213 Europe PMC199 |
| 2012 | Bechmann, L., Gastaldelli, A., Vetter, D., Patman, G., Pascoe, L., Hannivoort, R., . . . Reeves, H. (2012). Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology, 55(4), 1083-1093. Scopus62 WoS58 Europe PMC52 |
| 2012 | Simeon-Dubach, D., Burt, A. D., & Hall, P. A. (2012). Quality really matters: the need to improve specimen quality in biomedical research. Histopathology, 61(6), 1003-1005. Scopus15 WoS12 Europe PMC9 |
| 2012 | Perugorria, M., Wilson, C., Zeybel, M., Walsh, M., Amin, S., Robinson, S., . . . Mann, J. (2012). Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation. Hepatology, 56(3), 1129-1139. Scopus122 WoS112 Europe PMC104 |
| 2012 | Kelly, P. J., Spence, R., Dasari, B. V., Burt, A. D., Taylor, M., & Loughrey, M. B. (2012). Primary hepatocellular carcinoma of the pancreas: a case report and review of the heterogeneous group of pancreatic hepatoid carcinomas. Histopathology, 60(6), 1012-1015. Scopus21 WoS22 Europe PMC22 |
| 2012 | Elsharkawy, A. M., McPherson, S., Masson, S., Burt, A. D., Dawson, R. T., & Hudson, M. (2012). Cholestasis secondary to anabolic steroid use in young men. BMJ, 344(7843), e468-1-e468-3. Scopus31 WoS20 Europe PMC19 |
| 2011 | de Alwis, N., Aithal, G., Bugianesi, E., Leathart, J., Hudson, G., Pyle, A., . . . Day, C. P. (2011). Mitochondrial DNA does not contribute to the heritability of non-alcoholic fatty liver disease. Mitochondrion, 11(1), 234-235. Scopus4 WoS4 Europe PMC4 |
| 2011 | Ebrahimkhani, M., Oakley, F., Murphy, L., Mann, J., Moles, A., Perugorria, M., . . . Mann, D. (2011). Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nature Medicine, 17(12), 1668-1673. Scopus193 WoS171 Europe PMC154 |
| 2011 | Chan, A., & Burt, A. (2011). Liver cell dysplasia and early hepatocellular carcinoma. Diagnostic Histopathology, 17(12), 512-520. Scopus1 |
| 2011 | Griffin, S., Burt, A., & Jennings, N. (2011). Lymph node metastasis in early esophageal adenocarcinoma. Annals of Surgery, 254(5), 731-737. Scopus58 WoS50 Europe PMC40 |
| 2010 | Van Der Laan, L., Hudson, M., McPherson, S., Zondervan, P., Thomas, R., Kwekkeboom, J., . . . Metselaar, H. (2010). Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus. Transplantation Proceedings, 42(10), 4573-4577. Scopus8 WoS9 Europe PMC8 |
| 2010 | Rygiel, K., Robertson, H., Willet, J., Brain, J., Burt, A., Jones, D., & Kirby, J. (2010). T Cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection. Liver Transplantation, 16(5), 567-576. Scopus15 WoS11 Europe PMC9 |
| 2010 | McPherson, S., Stewart, S., Henderson, E., Burt, A., & Day, C. (2010). Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut, 59(9), 1265-1269. Scopus793 WoS723 Europe PMC649 |
| 2010 | Harte, A., da Silva, N., Creely, S., McGee, K., Billyard, T., Youssef-Elabd, E., . . . McTernan, P. (2010). Elevated endotoxin levels in non-alcoholic fatty liver disease. Journal of Inflammation, 7(15), 1-10. Scopus342 WoS317 Europe PMC274 |
| 2010 | Parkes, J., Roderick, P., Harris, S., Day, C., Mutimer, D., Collier, J., . . . Rosenberg, W. (2010). Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut, 59(9), 1245-1251. Scopus301 WoS268 Europe PMC241 |
| 2010 | Dongiovanni, P., Valenti, L., Rametta, R., Daly, A., Nobili, V., Mozzi, E., . . . Fargion, S. (2010). Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut, 59(2), 267-273. Scopus158 WoS140 Europe PMC125 |
| 2010 | Brain, J. G., & Burt, A. D. (2010). Abrikosoff's tumor and the hepatobiliary system: A curiosa revisited. Gastroenterology and Hepatology, 6(5), 337-338. |
| 2010 | Wallace, K., Flecknell, P., Burt, A., & Wright, M. (2010). Disrupted pancreatic exocrine differentiation and malabsorption in response to chronic elevated systemic glucocorticoid. American Journal of Pathology, 177(3), 1225-1232. Scopus20 WoS18 Europe PMC14 |
| 2010 | Gieling, R., Elsharkawy, A., Caamano, J., Cowie, D., Wright, M., Ebrahimkhani, M., . . . Mann, D. (2010). The c-Rel subunit of nuclear factor-κB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation. Hepatology, 51(3), 922-931. Scopus55 WoS53 Europe PMC50 |
| 2009 | De Alwis, N., Hudson, G., Burt, A., Day, C., & Chinnery, P. (2009). Human liver stem cells originate from the canals of hering. Hepatology, 50(3), 992-993. Scopus18 WoS15 Europe PMC16 |
| 2009 | Burt, A. (2009). Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology, 49(2), 658-664. Scopus722 WoS602 Europe PMC528 |
| 2009 | Frith, J., Day, C., Henderson, E., Burt, A., & Newton, J. (2009). Non-alcoholic fatty liver disease in older people. Gerontology, 55(6), 607-613. Scopus210 WoS180 Europe PMC153 |
| 2008 | Duconge, J., Merino, N., Alvarez, D., Beausoleil, I., Fernandez-Sanchez, E., Rodriguez, L., & Burt, A. (2008). Kinetics of monoclonal anti-epidermal growth factor receptor antibody (IOR EGF/R3)-induced apoptosis in human carcinoma bearing nude mice. Puerto Rico Health Sciences Journal, 27(1), 35-41. |
| 2008 | Gennery, A., Slatter, M., Rice, J., Hoefsloot, L., Barge, D., McLean-Tooke, A., . . . Johnson, D. (2008). Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome. Clinical and Experimental Immunology, 153(1), 75-80. Scopus106 WoS84 Europe PMC74 |
| 2008 | Rygiel, K., Robertson, H., Marshall, H., Pekalski, M., Zhao, L., Booth, T., . . . Kirby, J. (2008). Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Laboratory Investigation, 88(2), 112-123. Scopus225 WoS199 Europe PMC174 |
| 2008 | Wallace, K., Burt, A., & Wright, M. (2008). Liver fibrosis. Biochemical Journal, 411(1), 1-18. Scopus303 WoS369 Europe PMC212 |
| 2008 | Guha, I., Parkes, J., Roderick, P., Chattopadhyay, D., Cross, R., Harris, S., . . . Rosenberg, W. (2008). Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers. Hepatology, 47(2), 455-460. Scopus681 WoS591 Europe PMC528 |
| 2008 | Gieling, R., Burt, A., & Mann, D. (2008). Fibrosis and cirrhosis reversibility - molecular mechanisms. Clinics in Liver Disease, 12(4), 915-937. Scopus82 WoS68 Europe PMC58 |
| 2008 | Newton, J., Jones, D., Henderson, E., Kane, L., Wilton, K., Burt, A., & Day, C. (2008). Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease. Gut, 57(6), 807-813. Scopus180 WoS159 Europe PMC134 |
| 2008 | Tiniakos, D., Mathew, J., Kittas, C., & Burt, A. (2008). Ontogeny of human intrahepatic innervation. Virchows Archiv-An International Journal of Pathology, 452(4), 435-442. Scopus14 WoS12 Europe PMC11 |
| 2008 | Jones, D. F. J., Palmer, J. M., Burt, A. D., & Kirby, J. A. (2008). The specificity of liver inflammation in mouse models of primary biliary cirrhosis. Hepatology, 48(4), 1353-1354. Scopus1 Europe PMC1 |
| 2008 | Kirby, J. A., Robertson, H., Marshall, H. L., Rygiel, K. A., Hudson, M., Jones, D. E. J., & Burt, A. D. (2008). Epithelial to mesenchymal transition in primary sclerosing cholangitis. Liver International, 28(8), 1176-1177. Scopus6 WoS5 Europe PMC4 |
| 2008 | Hedge, M. M., Thompson, N. P., Burt, A. D., Day, C. P., & Reeves, H. (2008). Warfarin induced cholestatic jaundice in a patient receiving total parenteral nutrition. CME Gastroenterology, Hepatology & Nutrition, 9(1), 27-29. |
| 2007 | Haugk, B., El-Refaie, A., & Burt, A. D. (2007). Pathology of liver transplantation. Current Diagnostic Pathology, 13(1), 75-84. Scopus3 |
| 2007 | Wilson, C. H., Agarwal, K., Carter, V., Burt, A. D., Hubscher, S., Talbot, D., . . . Manas, D. M. (2007). Late humoral rejection in a compliant ABO-compatible liver transplant recipient (vol 82, pg 988, 2006). TRANSPLANTATION, 83(1), 70. |
| 2007 | Prabhu, V. R., & Burt, A. D. (2007). Pathology of liver tumours. Surgery, 25(1), 10-15. Scopus5 |
| 2007 | Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., . . . Day, C. P. (2007). The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 45(4), 846-854. Scopus2716 WoS2495 Europe PMC2197 |
| 2007 | Robertson, H., Kirby, J. A., Yip, W. W., Jones, D. E. J., & Burt, A. D. (2007). Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology, 45(4), 977-981. Scopus149 WoS128 Europe PMC117 |
| 2007 | Zhao, L., & Burt, A. D. (2007). The diffuse stellate cell system. Journal of Molecular Histology, 38(1), 53-64. Scopus75 WoS59 Europe PMC50 |
| 2007 | Wilson, C. H., Agarwal, K., Carter, V., Burt, A. D., Hübscher, S., Talbot, D., . . . Manas, D. M. (2007). Erratum: Late humoral rejection in a compliant ABO-compatible liver transplant recipient (Transplantation (2006) 82, (988)). Transplantation, 83(1), 70. |
| 2006 | Wilson, C. H., Agarwal, K., Talbot, D., Jaques, B. C., Manas, D. M., Carter, V., . . . Hübscher, S. (2006). Late humoral rejection in a compliant ABO-compatible liver transplant recipient [4]. Transplantation, 82(7), 988-989. Scopus37 WoS34 Europe PMC30 |
| 2006 | Benitez-Rajal, J., Lorite, M. J., Burt, A. D., Day, C. P., & Thompson, M. G. (2006). Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: Effects of platelet-derived growth factor and extracellular nucleotides. American Journal of Physiology Gastrointestinal and Liver Physiology, 291(5), G977-G986. Scopus12 WoS13 Europe PMC10 |
| 2006 | Mathew, J., Igbokwe, U. O., Morley, N., & Burt, A. D. (2006). Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous α 1-antitrypsin deficiency. Dermatology, 213(2), 147-149. |
| 2006 | Tyler, J. R., Robertson, H., Booth, T. A., Burt, A. D., & Kirby, J. A. (2006). Chronic allograft nephropathy: Intraepithelial signals generated by transforming growth factor-β and bone morphogenetic protein-7. American Journal of Transplantation, 6(6), 1367-1376. Scopus39 WoS37 Europe PMC31 |
| 2006 | Nielsen, S. U., Bassendine, M. F., Burt, A. D., Martin, C., Pumeechockchai, W., & Toms, G. L. (2006). Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. Journal of Virology, 80(5), 2418-2428. Scopus303 WoS283 Europe PMC248 |
| 2006 | Price, D. A., Bassendine, M. F., Norris, S. M., Golding, C., Toms, G. L., Schmid, M. L., . . . Donaldson, P. T. (2006). Apolipoprotein ε3 allele is associated with persistent hepatitis C virus infection. Gut, 55(5), 715-718. Scopus83 WoS75 Europe PMC65 |
| 2006 | Yip, W. W., & Burt, A. D. (2006). Alcoholic liver disease. Seminars in Diagnostic Pathology, 23(3-4), 149-160. Scopus157 WoS126 Europe PMC91 |
| 2006 | Fenwick, F., Bassendine, M. F., Agarwal, K., Bevitt, D., Pumeechockchai, W., Burt, A. D., & Toms, G. L. (2006). Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation. Journal of Clinical Pathology, 59(2), 174-178. Scopus18 WoS13 Europe PMC13 |
| 2005 | Ahmed El-Refaie, A. M., & Burt, A. D. (2005). Mast cells and c-Kit expression in liver allograft rejection. Histopathology, 47(4), 375-381. Scopus21 WoS14 Europe PMC10 |
| 2005 | Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., . . . Day, C. P. (2005). Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut, 54(7), 987-993. Scopus202 WoS190 Europe PMC153 |
| 2005 | Lamb, P. J., Griffin, S. M., Burt, A. D., Lloyd, J., Karat, D., & Hayes, N. (2005). Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. British Journal of Surgery, 92(1), 60-67. Scopus73 WoS62 Europe PMC57 |
| 2005 | Mathew, J., Leong, M. Y., Morley, N., & Burt, A. D. (2005). A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis. BMC Dermatology, 5(1), 6 pages. Scopus3 WoS2 Europe PMC2 |
| 2005 | Rai, R., Richardson, C., Flecknell, P., Robertson, H., Burt, A., & Manas, D. M. (2005). Study of apoptosis and heat shock protein (HSP) expression in hepatocytes following radiofrequency ablation (RFA). Journal of Surgical Research, 129(1), 147-151. Scopus85 Europe PMC60 |
| 2005 | Rostron, A., Carter, V., Mutunga, M., Cavanagh, G., O'Suilleabhain, C., Burt, A., . . . Manas, D. (2005). A case of acute humoral rejection in liver transplantation: Successful treatment with plasmapheresis and mycophenolate mofetil. Transplant International, 18(11), 1298-1301. Scopus31 WoS29 Europe PMC27 |
| 2004 | Rosenberg, W. M. C., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D., . . . Arthur, M. J. P. (2004). Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology, 127(6), 1704-1713. Scopus1002 WoS849 Europe PMC717 |
| 2004 | Palmer, J. M., Robe, A. J., Burt, A. D., Kirby, J. A., & Jones, D. E. J. (2004). Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology, 39(6), 1583-1592. Scopus24 WoS23 Europe PMC17 |
| 2004 | Nielsen, S. U., Bassendine, M. F., Burt, A. D., Bevitt, D. J., & Toms, G. L. (2004). Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver. Journal of General Virology, 85(6), 1497-1507. Scopus56 WoS58 Europe PMC44 |
| 2004 | Aithal, G. P., Haugk, B., Das, S., Card, T., Burt, A. D., & Record, C. O. (2004). Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: Are serial liver biopsies justified?. Alimentary Pharmacology and Therapeutics, 19(4), 391-399. Scopus132 WoS100 Europe PMC74 |
| 2004 | Robertson, H., Ali, S., McDonnell, B. J., Burt, A. D., & Kirby, J. A. (2004). Chronic Renal Allograft Dysfunction: The Role of T Cell-Mediated Tubular Epithelial to Mesenchymal Cell Transition. Journal of the American Society of Nephrology, 15(2), 390-397. Scopus109 WoS99 Europe PMC93 |
| 2003 | Roskams, T., Baptista, A., Bianchi, L., Burt, A., Callea, F., Denk, H., . . . Thaler, H. (2003). Histopathology of portal hypertension: A practical guideline. Histopathology, 42(1), 2-13. Scopus59 WoS40 Europe PMC33 |
| 2002 | Jones, D. E. J., Palmer, J. M., Burt, A. D., Walker, C., Robe, A. J., & Kirby, J. A. (2002). Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology, 36(3), 679-686. Scopus46 WoS40 Europe PMC34 |
| 2002 | Burt, A. D. (2002). Primary biliary cirrhosis and other ductopenic diseases. Clinics in Liver Disease, 6(2), 363-380. Scopus27 Europe PMC14 |
| 2002 | Agarwal, K., Jones, D. E. J., Watt, F. E., Burt, A. D., Floreani, A., & Bassendine, M. F. (2002). Familial primary biliary cirrhosis and autoimmune cholangitis. Digestive and Liver Disease, 34(1), 50-52. Scopus5 WoS4 Europe PMC3 |
| 2002 | Agarwal, K., Jones, D. E. J., Burt, A. D., Hudson, M., & James, O. F. W. (2002). Metastatic breast carcinoma presenting as acute liver failure and portal hypertension. American Journal of Gastroenterology, 97(3), 750-751. Scopus19 WoS12 Europe PMC12 |
| 2002 | Jones, D. E. J., Palmer, J. M., Bennett, K., Robe, A. J., Yeaman, S. J., Robertson, H., . . . Kirby, J. A. (2002). Investigation of a mechanism for accelerated breakdown of immune tolerance to the primary biliary cirrhosis-associated autoantigen, pyruvate dehydrogenase complex. Laboratory Investigation, 82(2), 211-219. Scopus25 WoS24 Europe PMC20 |
| 2002 | Prince, M. I., Burt, A. D., & Jones, D. E. J. (2002). Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut, 50(3), 436-439. Scopus190 WoS149 Europe PMC119 |
| 2002 | Lamb, P. J., Dresner, S. M., Lloyd, J., O'Driscoll, K., Burt, A. D., Karat, D., . . . Griffin, S. M. (2002). The sentinel node concept in the metastatic dissemination of oesophageal adenocarcinoma. BRITISH JOURNAL OF SURGERY, 89, 37. |
| 2001 | Burt, A. D. (2001). Steatosis and steatohepatitis. Current Diagnostic Pathology, 7(2), 141-147. Scopus10 |
| 2001 | Benitez, J., Lorite, M. J., Burt, A. D., Day, C. P., & Geerts, A. (2001). Identification of phospholipase D gene products in activated rat hepatic stellate cells - Stimulation by PDGF and nucleotides. JOURNAL OF HEPATOLOGY, 34, 90. |
| 2001 | Reeves, H. L., Burt, A. D., & Day, C. P. (2001). Integrin receptor expression changes in diseased hepatic stellate cells. GUT, 48, A108-A109. |
| 2001 | Aithal, G. P., Haugk, B., Gumustop, B., Burt, A. D., & Record, C. O. (2001). Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: Are serial liver biopsies justified?.. HEPATOLOGY, 34(4), 342A. |
| 2001 | Mohamed, M. A. S., Burt, A. D., Robertson, H., Kirby, J. A., & Talbot, D. (2001). TGF-β expression in protocol transplant liver biopsies: A comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1378-1380. WoS5 Europe PMC6 |
| 2001 | Robertson, H., Wong, W. K., Burt, A. D., Mohamed, M. A. S., Talbot, D., & Kirby, J. A. (2001). Relationship between TGFβ<sub>1</sub>, intratubular CD103 positive T cells and acute renal allograft rejection. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1159. WoS6 Europe PMC6 |
| 2001 | Jowett, S. L., Agarwal, K., Smith, B. C., Craig, W., Hewett, M., Bassendine, D. R., . . . Bassendine, M. F. (2001). Managing chronic hepatitis C acquired through intravenous drug use. QJM an International Journal of Medicine, 94(3), 153-158. Scopus57 WoS46 Europe PMC36 |
| 2001 | Robertson, H., Keong Wong, W., Talbot, D., Burt, A. D., & Kirby, J. A. (2001). Tubulitis after renal transplantation: Demonstration of an association between CD103+ T cells, transforming growth factor β1 expression and rejection grade. Transplantation, 71(2), 306-313. Scopus62 WoS55 Europe PMC46 |
| 2001 | Koeppen, H. K. W., Wright, B. D., Burt, A. D., Quirke, P., McNicol, A. M., Dybdal, N. O., . . . Hillan, K. J. (2001). Overexpression of HER2/neu in solid tumours: An immunohistochemical survey. Histopathology, 38(2), 96-104. Scopus152 WoS137 Europe PMC115 |
| 2001 | Burt, A. D. (2001). Autoimmune liver disease. CPD Bulletin Cellular Pathology, 3(2), 64-67. |
| 2001 | Drasar, P. (2001). Editorial. CHEMICKE LISTY, 95(4), 193. |
| 2000 | Reynaert, H., Burt, A., & Geerts, A. (2000). Prions in activated hepatic stellate cells: Not a surprise after all. Journal of Hepatology, 33(5), 838-841. Scopus4 WoS4 Europe PMC3 |
| 2000 | Jones, D. E. J., Palmer, J. M., Kirby, J. A., De Cruz, D. J., McCaughan, G. W., Sedgwick, J. D., . . . Bassendine, M. F. (2000). Experimental autoimmune cholangitis: A mouse model of immune-mediated cholangiopathy. Liver, 20(5), 351-356. Scopus33 WoS29 Europe PMC21 |
| 2000 | Reeves, H. L., Dack, C. L., Peak, M., Burt, A. D., & Day, C. P. (2000). Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. Journal of Hepatology, 32(3), 465-472. Scopus65 WoS59 Europe PMC45 |
| 2000 | Newton, J. L., Jones, D. E., Metcalf, J. V., Park, J. B., Burt, A. D., Bassendine, M. F., & James, O. F. W. (2000). Presentation and mortality of primary biliary cirrhosis in older patients. Age and Ageing, 29(4), 305-309. Scopus27 WoS16 Europe PMC16 |
| 2000 | Reeves, H. L., Thompson, M. G., Dack, C. L., Burt, A. D., & Day, C. P. (2000). The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cells. Hepatology, 31(1), 95-100. Scopus29 WoS27 Europe PMC19 |
| 2000 | Bennett, K. M., Robertson, H., Bone, M., Burt, A. D., Kirby, J. A., & Jones, D. E. (2000). Immunohistochemical analaysis of portal tract changes in experimental autoimmune cholangitis, a murine model of non-suppurative destructive cholangitis (NSDC).. HEPATOLOGY, 32(4), 171A. |
| 2000 | Allen, M. (2000). Editorial. Outskirts, 7(4), 270. |
| 2000 | Eza, D., Burr, A. W., O'Toole, K., & Burt, A. D. (2000). Inhibition of non-parenchymal cell responses to acute liver injury using neutralising anti-growth factor antibodies. JOURNAL OF PATHOLOGY, 190, 12A. |
| 2000 | Lorite, M. J., Benitez, J., Burt, A. D., Day, C. P., & Thompson, M. G. (2000). Nucleotides stimulate protein synthesis in hepatic stellate cells: Potential role of phospholipase D - Mediated lipid hydrolysis.. JOURNAL OF PATHOLOGY, 190, 4A. |
| 2000 | Burt, A. D., Jones, D. E. J., Palmer, J. M., Kirby, J. A., DeCruz, D. J., McCaughan, G. W., . . . Bassendine, M. F. (2000). Histopathology of experimental autoimmune cholangitis - a mouse model of primary biliary cirrhosis. JOURNAL OF PATHOLOGY, 190, 3A. |
| 2000 | Burt, A. D. (2000). Viral hepatitis in Western Europe. JOURNAL OF PATHOLOGY, 190, 28A. |
| 2000 | Bone, M. H., Jones, D. E., Kirby, J. A., Robertson, H., Burt, A. D., Jawahari, A., & Hudson, M. (2000). Ulcerative colitis:: An investigation of the potential role played by a <SUP>E</SUP>B<sub>7</sub> +VE T-cells.. GASTROENTEROLOGY, 118(4), A1334. |
| 1999 | Fenwick, F., Bevitt, D., Burt, A. D., Pumeechockchai, W., Bassendine, M. F., & Toms, G. L. (1999). Detection of hepatitis C virus structural and nonstructural proteins by immunohistochemistry.. HEPATOLOGY, 30(4), 208A. |
| 1999 | Smith, B. C., Grove, J., Burt, A. D., & Bassendine, M. F. (1999). No evidence for involvement of interleukin-10 (IL-10) promoter gene polymorphisms in infuencing outcome of hepatitis C virus infection. HEPATOLOGY, 30(4), 590A. |
| 1999 | Reeves, H. L., Thompson, M. G., Burt, A. D., & Day, C. P. (1999). Signal cascade cross-talk in PDGF-induced HSC proliferation. GUT, 44, A97. |
| 1999 | Jones, D. E., Palmer, J. M., Yeaman, S. J., Kirby, J. A., Bassendine, M. F., & Burt, A. D. (1999). The time-course of bile duct lesion development in experimental autoimmune cholangitis (a mouse model of primary biliary cirrhosis-PBC).. HEPATOLOGY, 30(4), 564A. |
| 1999 | Case, M. C., Burt, A. D., Hughes, J., Palmer, J. M., Collier, J. D., Bassendine, M. F., . . . Major, G. N. (1999). Erratum: Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol (Journal of Immunological Methods (1999) 223 (93-106)). Journal of Immunological Methods, 226(1-2), 189-190. |
| 1999 | Jones, D. E., Palmer, J. M., Yeaman, S. J., Kirby, J. A., Bassendine, M. F., & Burt, A. D. (1999). The time-course of bile duct lesion development in experimental autoimmune cholangitis (A mouse model of primary biliary cirrhosis -PBC).. HEPATOLOGY, 30(4), 318A. WoS2 |
| 1999 | Case, M. C., Burt, A. D., Hughes, J., Palmer, J. M., Collier, J. D., Bassendine, M. F., . . . Major, G. N. (1999). Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol (vol 223, pg 93, 1999). JOURNAL OF IMMUNOLOGICAL METHODS, 226(1-2), 189-190. |
| 1999 | Wright, C., Strauss, S., Toole, K., Burt, A. D., & Robson, S. C. (1999). Composition of the pulmonary interstitium during normal development of the human fetus. Pediatric and Developmental Pathology, 2(5), 424-431. Scopus19 WoS16 Europe PMC14 |
| 1999 | Burt, A. D. (1999). Pathobiology of hepatic stellate cells. Journal of Gastroenterology, 34(3), 299-304. Scopus46 WoS42 Europe PMC33 |
| 1999 | James, O. E. W., Bhopal, R., Howel, D., Gray, J., Burt, A. D., & Metcalf, J. V. (1999). Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology, 30(2), 390-394. Scopus217 WoS191 Europe PMC154 |
| 1999 | Jones, D. E. J., James, O. E. W., Portmann, B., Burt, A. D., Williams, R., & Hudson, M. (1999). Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology, 30(1), 53-57. Scopus103 WoS78 Europe PMC66 |
| 1999 | Case, M. C., Burt, A. D., Hughes, J., Palmer, J. M., Collier, J. D., Bassendine, M. F., . . . Major, G. N. (1999). Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol. Journal of Immunological Methods, 223(1), 93-106. Scopus17 WoS12 Europe PMC11 |
| 1999 | Lorite, M. J., Benitez, J., Bleazard, L., Burt, A. D., Day, C. P., & Thompson, M. G. (1999). Stimulation of protein and DNA synthesis by ATP in hepatic stellate cells: Potential role of phospholipase D-mediated lipid hydrolysis.. HEPATOLOGY, 30(4), 487A. |
| 1998 | Burr, A. W., Toole, K., Chapman, C., Hines, J. E., & Burt, A. D. (1998). Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. Journal of Pathology, 185(3), 298-302. Scopus64 WoS55 Europe PMC45 |
| 1998 | Green, S. E., Chapman, P., Burn, J., Burt, A. D., Bennett, M., Appleton, D. R., . . . Mathers, J. C. (1998). Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer. Gut, 43(1), 85-92. Scopus15 WoS16 Europe PMC21 |
| 1998 | Olivieri, N. F., Brittenham, G. M., Mclaren, C. E., Templeton, D. M., Cameron, R. G., Mcclelland, R. A., . . . Fleming, K. A. (1998). Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. New England Journal of Medicine, 339(7), 417-423. Scopus377 WoS320 Europe PMC246 |
| 1998 | Smith, B. C., Grove, J., Guzail, M. A., Day, C. P., Daly, A. K., Burt, A. D., & Bassendine, M. F. (1998). Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology, 27(6), 1695-1699. Scopus219 WoS191 Europe PMC136 |
| 1998 | Karayiannis, P., Brind, A. M., Pickering, J., Mathew, J., Burt, A. D., Hess, G., . . . Thomas, H. C. (1998). Hepatitis G virus does not cause significant liver disease after liver transplantation. Journal of Viral Hepatitis, 5(1), 35-42. Scopus13 WoS8 Europe PMC7 |
| 1998 | Johnson, S. J., Burr, A. W., Toole, K., Dack, C. L., Mathew, J., & Burt, A. D. (1998). Macrophage and hepatic stellate cell responses during experimental hepatocarcinogenesis. Journal of Gastroenterology and Hepatology Australia, 13(2), 145-151. Scopus17 WoS19 Europe PMC12 |
| 1998 | Grove, J., Daly, A. K., Burt, A. D., Guzail, M., James, O. F. W., Bassendine, M. F., & Day, C. P. (1998). Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut, 43(2), 262-266. Scopus92 WoS74 Europe PMC48 |
| 1998 | Smith, B. C., Grove, J., Day, C. P., Daly, A. K., Burt, A. D., & Bassendine, M. F. (1998). Heterozygosity for haemochromatosis is associated with more fibrosis in chronic hepatitis C. GUT, 43(1), 154. |
| 1998 | Reeves, H. L., Peak, M., Burt, A. D., & Day, C. P. (1998). The antifibrogenic effect of interferon-α is via inhibition of p38 map kinase activity. GUT, 43(1), 152. |
| 1998 | Burt, A. D., Mutton, A., & Day, C. P. (1998). Diagnosis and interpretation of steatosis and steatohepatitis. Seminars in Diagnostic Pathology, 15(4), 246-258. Scopus267 WoS217 Europe PMC144 |
| 1998 | Reeves, H. L., Peak, M., Burt, A. D., & Day, C. P. (1998). Stress-activated protein kinases (SAPKs) are involved in the activation of hepatic stellate cells. GUT, 43(1), 151. |
| 1998 | Thompson, M. G., Dack, C., Reeves, H. L., Burt, A. D., & Day, C. P. (1998). PDGF but not TGFα activates phospholipase C and phospholipase D mediated lipid hydrolysis in hepatic stellate cells.. HEPATOLOGY, 28(4), 299A. WoS1 |
| 1998 | Newton, J. L., Jones, D. E. J., Metcalf, J. V., Burt, A. D., Bassendine, M. F., & James, O. F. W. (1998). The presentation of Primary Biliary Cirrhosis in the elderly.. GASTROENTEROLOGY, 114(4), A1311. WoS1 |
| 1998 | Burt, A. D. (1998). Untitled. LIVER, 18(1), 1. |
| 1998 | Grove, J., Daly, A. K., Burt, A. D., Guzail, M., Bassendine, M. F., & Day, C. P. (1998). Do HLA-H mutations influence liver iron content or disease risk in alcoholics?. GUT, 43(1), 153-154. |
| 1998 | Newton, J. L., Jones, D. E. J., Metcalf, J. V., Burt, A. D., Bassendine, M. F., & James, O. F. W. (1998). Primary biliary cirrhosis in the elderly: Increased liver related mortality despite similar clinical features at presentation.. HEPATOLOGY, 28(4), 540A. |
| 1997 | Park, J. B., Hudson, M., Gray, S., & Burt, A. D. (1997). Abnormalities of portal tract vasculature in primary biliary cirrhosis. JOURNAL OF PATHOLOGY, 181, A49. |
| 1997 | Smith, B. C., Chapman, C. E., Burt, A. D., Toms, G. L., & Bassendine, M. F. (1997). Post-transfusion hepatitis C: Variable outcome in a cohort of donor-recipient pairs. GUT, 41, A129. |
| 1997 | Grove, J., Daly, A. K., Burt, A. D., Guzail, M., Bassendine, M. P., & Day, C. P. (1997). HLA-H mutations, hepatic iron content and risk of advanced liver disease in alcoholics.. HEPATOLOGY, 26(4), 585. |
| 1997 | Smith, B. C., Grove, J., Day, C. P., Daly, A. K., Burt, A. D., & Bassendine, M. F. (1997). Heterozygosity for haemochromatosis is associated with more fibrosis in chronic hepatitis C.. HEPATOLOGY, 26(4), 1899. |
| 1997 | Chapman, C., Mathew, J., Milton, I. D., Piggott, N., Steward, M., & Burt, A. D. (1997). Distribution of c-met protein in normal human liver and following acute and chronic liver injury. JOURNAL OF PATHOLOGY, 181, A10. |
| 1997 | Reeves, H. L., Peak, M., Burt, A. D., & Day, C. P. (1997). The role of stress-activated protein kinases in the activation of hepatic stellate cells.. HEPATOLOGY, 26(4), 1277. WoS1 |
| 1997 | Reeves, H. L., Peak, M., Burt, A. D., & Day, C. P. (1997). Interferon alpha inhibits p38 MAP kinase activity in hepatic stellate cells.. HEPATOLOGY, 26(4), 1276. WoS1 |
| 1997 | Newton, J. L., Burt, A. D., Park, J. B., Mathew, J., Bassendine, M. R., & James, O. F. W. (1997). Autoimmune hepatitis in older patients. Age and Ageing, 26(6), 441-444. Scopus60 WoS44 Europe PMC32 |
| 1997 | Smith, B. C., Chapman, C. E., Burt, A. D., Toms, G. L., & Bassendine, M. F. (1997). Outcome of post-transfusion hepatitis C: Disease severity in blood-component recipients and their implicated donors. QJM an International Journal of Medicine, 90(9), 587-592. Scopus12 WoS11 Europe PMC9 |
| 1997 | Case, M., Major, G. N., Bassendine, M. F., & Burt, A. D. (1997). The universality of immuno-PCR for ultrasensitive antigen detection. BIOCHEMICAL SOCIETY TRANSACTIONS, 25(2), S374. WoS13 Europe PMC8 |
| 1997 | Wright, C., Burt, A. D., Strauss, S., Toole, K., & Robson, S. C. (1997). Cell proliferation in early human lung development.. JOURNAL OF PATHOLOGY, 182, A49. |
| 1996 | Brind, A. M., Watson, J. P., Burt, A., Kestevan, P., Wallis, J., Proctor, S. J., & Bassendine, M. F. (1996). Non-Hodgkin's lymphoma and hepatitis C virus infection. Leukemia and Lymphoma, 21(1-2), 127-130. Scopus65 WoS65 Europe PMC45 |
| 1996 | Ball, S. G., Davison, J. M., Burt, A. D., McNicol, A. M., & Baylis, P. H. (1996). Cushing's syndrome secondary to ectopic ACTH secretion from a primary ovarian carcinoma. Clinical Endocrinology, 45(6), 775-778. Scopus14 WoS15 Europe PMC9 |
| 1996 | Reeves, H. L., Burt, A. D., Wood, S., & Day, C. P. (1996). Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. Journal of Hepatology, 25(5), 677-683. Scopus137 WoS122 Europe PMC102 |
| 1996 | Morris, A. A. M., Singh-Kler, R., Perry, R. H., Griffiths, P. D., Burt, A. D., Chee Pian Wong., . . . Turnbull, D. M. (1996). Respiratory chain dysfunction in progressive neuronal degeneration of childhood with liver disease. Journal of Child Neurology, 11(5), 417-419. Scopus13 WoS11 Europe PMC6 |
| 1996 | Burr, A. W., Toole, K., Mathew, J., Hines, J. E., Chapman, C., & Burt, A. D. (1996). Transforming growth factor-α expression is altered during experimental hepatocarcinogenesis. Journal of Pathology, 179(3), 276-282. Scopus21 WoS21 Europe PMC16 |
| 1996 | Hinchliffe, S. A., Woods, S., Gray, S., & Burt, A. D. (1996). Cellular distribution of androgen receptors in the liver. Journal of Clinical Pathology, 49(5), 418-420. Scopus13 WoS11 Europe PMC8 |
| 1996 | Watson, J. P., Brind, A. M., Chapman, C. E., Bates, C. L., Gould, F. K., Johnson, S. J., . . . Bassendine, M. F. (1996). Hepatitis C virus: Epidemiology and genotypes in the north east of England. Gut, 38(2), 269-276. Scopus69 WoS59 Europe PMC45 |
| 1996 | Leon, M. P., Bassendine, M. F., Gibbs, P., Burt, A. D., Thick, M., & Kirby, J. A. (1996). Hepatic allograft rejection: Regulation of the immunogenicity of human intrahepatic biliary epithelial cells. Liver Transplantation and Surgery, 2(1), 37-45. Scopus11 Europe PMC8 |
| 1996 | Mathew, J., Geerts, A., & Burt, A. D. (1996). Pathobiology of hepatic stellate cells. Hepato Gastroenterology, 43(7), 72-91. Scopus47 WoS35 Europe PMC28 |
| 1996 | Burt, A. D. (1996). Special topic - Hepatic inflammation and fibrogenesis. Hepato Gastroenterology, 43(7), 2-3. |
| 1996 | Goldin, R. D., Goldin, J. G., Burt, A. D., Dhillon, P. A., Hubscher, S., Wyatt, J., & Patel, N. (1996). Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. Journal of Hepatology, 25(5), 649-654. Scopus151 WoS131 Europe PMC110 |
| 1996 | Burr, A. W., Hillan, K. J., McLaughlin, K. E., Ferrier, R., Chapman, C., Mathew, J., & Burt, A. D. (1996). Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis. Hepatology, 24(5), 1282-1287. Scopus24 WoS23 Europe PMC11 |
| 1996 | Newton, J. L., Burt, A. D., Park, J. B., Mathew, J., Bassendine, M. F., & James, O. F. W. (1996). Is the new international diagnostic scoring system for autoimmune hepatitis too rigid?. HEPATOLOGY, 24(4), 434. |
| 1996 | Case, M., Major, G. N., Bassendine, M. F., & Burt, A. D. (1996). The universality of immuno-PCR for ultrasensitive antigen detection. IMMUNOLOGY, 89, OH394. |
| 1996 | Mathew, J., Mines, J. E., Obafunwa, J. O., Burr, A. W., Toole, K., & Burt, A. D. (1996). CD44 is expressed in hepatocellular carcinomas showing vascular invasion. Journal of Pathology, 179(1), 74-79. Scopus71 WoS48 Europe PMC42 |
| 1996 | Tiniakos, D. G., Lee, J. A., & Burt, A. D. (1996). Innervation of the liver: Morphology and function. Liver, 16(3), 151-160. Scopus63 WoS46 Europe PMC36 |
| 1996 | Collier, J. D., Bassendine, M. F., Burt, A. D., & Major, G. N. (1996). Characterisation of the DNA repair enzyme for O6-methylguanine in cirrhosis. Journal of Hepatology, 25(2), 158-165. Scopus16 WoS14 Europe PMC9 |
| 1996 | Anderson, J. J., Birch, P. J., McIntosh, G. G., Parr, A., Burt, A. D., Lennard, T. W. J., . . . Angus, B. (1996). Over expression of CD44 variants acts as a useful secondary indicator of prognosis in patients with carcinomas of the breast. JOURNAL OF PATHOLOGY, 179, A19. |
| 1996 | Burt, A. D. (1996). Hepatic inflammation and fibrogenesis. HEPATO-GASTROENTEROLOGY, 43(7), 1. |
| 1996 | Reeves, H. L., Burt, A. D., & Day, C. P. (1996). The antiproliferative effect of IFN alpha correlates with inhibition of MAP kinase activation. HEPATOLOGY, 23(1), T53. |
| 1995 | BURR, A. W., TOOLE, K., HINES, J. E., CHAPMAN, C., & BURT, A. D. (1995). ANTI-HEPATOCYTE GROWTH-FACTOR ANTIBODY INHIBITS THE IN-VIVO PROLIFERATIVE RESPONSE OF HEPATOCYTES TO ACUTE LIVER-INJURY. GASTROENTEROLOGY, 108(4), A1041. |
| 1995 | Farrell, D. J., Hines, J. E., Walls, A. F., Kelly, P. J., Bennett, M. K., & Burt, A. D. (1995). Intrahepatic mast cells in chronic liver diseases. Hepatology, 22(4 PART 1), 1175-1181. Scopus134 WoS117 Europe PMC84 |
| 1995 | Johnson, S. J., Toole, K., Fraser, R., Rogers, G. W. T., Dobbs, B. R., & Burt, A. D. (1995). Methylprednisolone does not inhibit the nonparenchymal cell responses to dimethylnitrosamine-induced liver injury. International Hepatology Communications, 4(4), 201-206. |
| 1995 | Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995). The natural history of nonalcoholic fatty liver: A follow-up study. Hepatology, 22(6), 1714-1719. Scopus873 WoS741 Europe PMC630 |
| 1995 | Teli, M. R., Day, C. P., James, O. F. W., Burt, A. D., & Bennett, M. K. (1995). Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet, 346(8981), 987-990. Scopus464 WoS376 Europe PMC314 |
| 1995 | Leon, M. P., Kirby, J. A., Gibbs, P., Burt, A. D., & Bassendine, M. F. (1995). Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. Journal of Hepatology, 22(5), 591-595. Scopus53 WoS49 Europe PMC27 |
| 1995 | FARRELL, D. (1995). Intrahepatic mast cells in chronic liver diseases*1. Hepatology, 22(4), 1175-1181. |
| 1995 | Macey, A. C., Burke, F. D., Abbott, K., Barton, N. J., Bradbury, E., Bradley, A., . . . Woodbridge, S. (1995). Outcomes of hand surgery. Journal of Hand Surgery, 20(6), 841-855. Scopus170 Europe PMC126 |
| 1995 | REEVES, H. L., BURT, A. D., & DAY, C. P. (1995). MAPKINASE AND LIPID-DERIVED SIGNAL-TRANSDUCTION CASCADES IN HEPATIC STELLATE CELL-PROLIFERATION. HEPATOLOGY, 22(4), 693. |
| 1995 | M-H Ho, A., Contardi, L. A. H., Day, C. P., Burt, A. D., & James, O. F. W. (1995). Pure alcoholic fatty liver and progression to cirrhosis or fibrosis. Lancet, 346(8989), 1562-1563. Scopus5 WoS3 Europe PMC4 |
| 1995 | TELI, M. (1995). The natural history of nonalcoholic fatty liver: A follow-up study. Hepatology, 22(6), 1714-1719. |
| 1994 | Johnson, S. J., Mathew, J., MacSween, R. N. M., Bennett, M. K., & Burt, A. D. (1994). Post-infantile giant cell hepatitis: Histological and immunohistochemical study. Journal of Clinical Pathology, 47(11), 1022-1027. Scopus55 WoS40 Europe PMC38 |
| 1994 | Mathew, J., Hines, J. E., James, O. F. W., & Burt, A. D. (1994). Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury. Journal of Hepatology, 20(4), 537-541. Scopus32 WoS27 Europe PMC20 |
| 1994 | TURNER, I. B., MYSZOR, M., MITCHISON, H. C., BENNETT, M. K., BURT, A. D., & JAMES, O. F. W. (1994). A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. Journal of Gastroenterology and Hepatology, 9(2), 162-168. Scopus40 WoS42 Europe PMC36 |
| 1994 | Collier, J. D., Carpenter, M., Burt, A. D., & Bassendine, M. F. (1994). Expression of mutant p53 protein in hepatocellular carcinoma. Gut, 35(1), 98-100. Scopus23 WoS21 Europe PMC10 |
| 1994 | MATHEW, J., HINES, J. E., TOOLE, K., JOHNSON, S. J., JAMES, O. F. W., & BURT, A. D. (1994). Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis. Histopathology, 25(1), 65-70. Scopus34 WoS35 Europe PMC24 |
| 1994 | TEILI, M. R., DAY, C. P., BURT, A. D., & JAMES, O. F. W. (1994). PATTERN OF STEATOSIS AND CONTINUED DRINKING PREDICT RISK OF PROGRESSION TO CIRRHOSIS IN PURE ALCOHOLIC FATTY LIVER. HEPATOLOGY, 20(4), A319. WoS1 |
| 1994 | BURR, A. W., TOOLE, K., MATHEW, J., HINES, J. E., CHAPMAN, C., & BURT, A. D. (1994). TRANSFORMING GROWTH-FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN EXPERIMENTAL HEPATOCARCINOGENESIS. HEPATOLOGY, 19(4), I46. |
| 1994 | REEVES, H. L., BURT, A. D., WOOD, S., JAMES, O. F. W., & DAY, C. P. (1994). LIPOCYTE ACTIVATION OCCURS IN THE ABSENCE OF HEPATITIS IN ALCOHOLIC LIVER-DISEASE AND CORRELATES WITH THE SEVERITY OF STEATOSIS. HEPATOLOGY, 20(4), A318. WoS2 |
| 1994 | COLLIER, J. D., MAJOR, G. N., BURT, A. D., & BASSENDINE, M. F. (1994). ANALYSIS OF DNA-REPAIR IN CIRRHOSIS OF DIFFERENT ETIOLOGIES. GUT, 35(5), A722. |
| 1993 | Burt, A. D., Le Bail, B., Balabaud, C., & Bioulac-Sage, P. (1993). Morphologic investigation of sinusoidal cells. Seminars in Liver Disease, 13(1), 21-38. Scopus60 WoS40 Europe PMC25 |
| 1993 | HINES, J. E., JOHNSON, S. J., & BURT, A. D. (1993). INVIVO RESPONSES OF MACROPHAGES AND PERISINUSOIDAL CELLS TO CHOLESTATIC LIVER-INJURY. AMERICAN JOURNAL OF PATHOLOGY, 142(2), 511-518. WoS141 |
| 1993 | BURT, A. D., HUBSCHER, S. G., & HINES, J. E. (1993). PECAM-1 (CD31) IS EXPRESSED BY SINUSOIDAL ENDOTHELIAL-CELLS AND ACTIVATED ITO CELLS (LIPOCYTES) IN HUMAN LIVER. HEPATOLOGY, 18(4), A198. |
| 1993 | BURT, A. D., & MacSWEEN, R. N. M. (1993). Bile duct proliferation—its true significance?. Histopathology, 23(6), 599-602. Scopus49 WoS44 Europe PMC36 |
| 1993 | Day, C. P., Burt, A. D., Brown, A. S. M., Bennett, M. K., Farrell, D. J., James, O. F. W., & Yeaman, S. J. (1993). Plasma membrane form of phosphatidate phosphohydrolase: A possible role in signal transduction during liver fibrogenesis. Clinical Science, 85(3), 281-287. Scopus6 WoS7 Europe PMC5 |
| 1993 | Harrison, D. J., & Burt, A. D. (1993). Pathology of alcoholic liver disease. Bailliere S Clinical Gastroenterology, 7(3), 641-662. Scopus12 WoS11 Europe PMC7 |
| 1993 | Collier, J. D., Guo, K., Gullick, W. J., Bassendine, M. F., & Burt, A. D. (1993). Expression of transforming growth factor alpha in human hepatocellular carcinoma. Liver, 13(3), 151-155. Scopus30 WoS33 Europe PMC17 |
| 1993 | Burt, A. D. (1993). Cellular and molecular aspects of hepatic fibrosis. Journal of Pathology, 170(2), 105-114. Scopus134 WoS128 Europe PMC96 |
| 1993 | Burr, A. W., Carpenter, M. R., Hines, J. E., Gullick, W. J., & Burt, A. D. (1993). Intrahepatic distribution of transforming growth factor‐alpha (TGFα) during liver regeneration following carbon tetrachlorideinduced necrosis. Journal of Pathology, 170(1), 95-100. Scopus42 WoS45 Europe PMC28 |
| 1993 | Hines, J. E., Johnson, S. J., & Burt, A. D. (1993). In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. American Journal of Pathology, 142(2), 511-518. Scopus142 Europe PMC97 |
| 1993 | Collier, J. D., Guo, K., Bassendine, M. F., Major, G. N., & Burt, A. D. (1993). Deficient repair of DNA lesion O6-methylguanine in cirrhosis. Lancet, 341(8839), 207-208. Scopus13 WoS16 Europe PMC9 |
| 1993 | Franceschi, S., Boyle, P., Maisonneuve, P., La Vecchia, C., Burt, A. D., Kerr, D. J., & MacFarlane, G. J. (1993). The epidemiology of thyroid carcinoma.. Critical Reviews in Oncogenesis, 4(1), 25-52. Scopus167 WoS143 Europe PMC73 |
| 1993 | COLLIER, J. D., MAJOR, G. N., BURT, A. D., & BASSENDINE, M. F. (1993). CHARACTERIZATION OF THE DNA-REPAIR PROTEIN O6-METHYLGUANINE-DNA METHYLTRANSFERASE IN CIRRHOSIS. HEPATOLOGY, 18(4), A182. |
| 1992 | Burke, T., Seidler, R., & Smith, H. (1992). Untitled. MOLECULAR ECOLOGY, 1(1), 1. WoS5 |
| 1992 | Johnson, S. J., Hines, J. E., & Burt, A. D. (1992). Phenotypic modulation of perisinusoidal cells following acute liver injury: A quantitative analysis. International Journal of Experimental Pathology, 73(6), 765-772. Scopus38 WoS36 Europe PMC29 |
| 1992 | GRIFFITHS, M. R., SHEPHERD, M., FERRIER, R., SCHUPPAN, D., JAMES, O. F. W., & BURT, A. D. (1992). Light microscopic and ultrastructural distribution of type VI collagen in human liver: alterations in chronic biliary disease. Histopathology, 21(4), 335-344. Scopus28 WoS23 Europe PMC18 |
| 1992 | Burt, A. D. (1992). Liver fibrosis. British Medical Journal, 305(6853), 537-538. Scopus7 WoS6 Europe PMC4 |
| 1992 | Boon, A. P., Hubscher, S. G., Lee, J. A., Hines, J. E., & Burt, A. D. (1992). Hepatic reinnervation following orthotopic liver transplantation in man. Journal of Pathology, 167(2), 217-222. Scopus41 WoS38 Europe PMC34 |
| 1992 | BLOXHAM, C. A., HENDERSON, D. C., HAMPSON, J., & BURT, A. D. (1992). Nodular regenerative hyperplasia of the liver in Behçet's disease. Histopathology, 20(5), 452-454. Scopus10 WoS3 Europe PMC3 |
| 1992 | Allison, M. C., Mowat, A., McCruden, E. A. B., McGregor, E., Burt, A. D., Briggs, J. D., . . . Mills, P. R. (1992). The spectrum of chronic liver disease in renal transplant recipients. QJM, 83(2), 355-367. Scopus22 WoS20 Europe PMC9 |
| 1992 | Collier, J. D., Guo, K., Mathew, J., May, F. E. B., Bennett, M. K., Corbett, I. P., . . . Burt, A. D. (1992). c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma. Journal of Hepatology, 14(2-3), 377-380. Scopus50 WoS46 Europe PMC35 |
| 1992 | Johnson, S. J., Hines, J. E., & Burt, A. D. (1992). Immunolocalization of proliferating perisinusoidal cells in rat liver. Histochemical Journal, 24(2), 67-72. Scopus20 WoS20 Europe PMC16 |
| 1992 | Lee, J. A., Ahmed, Q., Hines, J. E., & Burt, A. D. (1992). Disappearance of hepatic parenchymal nerves in human liver cirrhosis. Gut, 33(1), 87-91. Scopus48 WoS42 Europe PMC37 |
| 1992 | Mathew, J., Cattan, A. R., Hall, A. G., Hines, J. E., Nelson, R., Eastham, E., & Burt, A. D. (1992). Glutathione S-transferases in neonatal liver disease. Journal of Clinical Pathology, 45(8), 679-683. Scopus22 WoS14 Europe PMC12 |
| 1992 | Epstein, M. L., Windebank, K. P., Burt, A. D., Thomas, L., & Cant, A. J. (1992). CD30 expression by peripheral blood monocytes and hepatic macrophages in a child with miliary tuberculosis. Journal of Clinical Pathology, 45(7), 638-639. Scopus9 WoS9 Europe PMC8 |
| 1992 | Johnson, S. J., Hines, J. E., & Burt, A. D. (1992). Macrophage and perisinusoidal cell kinetics in acute liver injury. Journal of Pathology, 166(4), 351-358. Scopus115 WoS107 Europe PMC75 |
| 1992 | DAY, C. P., BROWN, A. S. M., BENNETT, M. K., BURT, A. D., JAMES, O. F. W., & YEAMAN, S. J. (1992). PLASMA-MEMBRANE PHOSPHATIDATE PHOSPHOHYDROLASE - A ROLE IN LIVER-REGENERATION. HEPATOLOGY, 16(4), A141. |
| 1992 | TINIAKOS, D. G., HARRISON, D., & BURT, A. D. (1992). DETECTION OF MALLORY BODIES IN HUMAN LIVER BIOPSIES BY IMMUNOLOCALIZATION OF UBIQUITIN - COMPARISON WITH OTHER HISTOCHEMICAL AND IMMUNOHISTOCHEMICAL METHODS. HEPATOLOGY, 16(2), 601. WoS1 |
| 1992 | TINIAKOS, D., NIKOLAIDOU, A., MOUROUTI, G., LYRA, T., SPANDIDOS, D., & TINIAKOS, G. (1992). ONCOGENE EXPRESSION AND HBV/TUMOR MARKERS IN HUMAN LIVER-DISEASE. HEPATOLOGY, 16(2), 601. WoS1 |
| 1992 | GRIFFITHS, M. R., BURT, A. D., HILLAN, K. J., & MACSWEEN, R. N. M. (1992). LOCALIZATION OF TYPE-I PROCOLLAGEN MESSENGER-RNA IN RAT-LIVER. JOURNAL OF PATHOLOGY, 168, A149. |
| 1992 | BURR, A. W., CARPENTER, M. R., & BURT, A. D. (1992). IMMUNOREACTIVE TRANSFORMING GROWTH FACTOR-ALPHA IN RAT-LIVER FOLLOWING ACUTE CARBON TETRACHLORIDE-INDUCED INJURY. HEPATOLOGY, 16(2), 520. |
| 1991 | MATHEW, J., HALL, A., CATTAN, A., HINES, J. E., & BURT, A. D. (1991). GLUTATHIONE S-TRANSFERASES IN NEONATAL LIVER-DISEASE. JOURNAL OF PATHOLOGY, 163(2), A178. |
| 1991 | JOHNSON, S. J., HINES, J. E., & BURT, A. D. (1991). PERISINUSOIDAL (ITO) CELL-PROLIFERATION AND PHENOTYPIC MODULATION IN ACUTE LIVER-INJURY. GUT, 32(7), A837. |
| 1991 | COLLIER, J. D., GUO, K., GULLICK, W. J., CHALLEN, C., BURT, A. D., & BASSENDINE, M. F. (1991). TRANSFORMING GROWTH-FACTOR ALPHA (TGF-ALPHA) - A ROLE IN HUMAN HEPATOCARCINOGENESIS BY AN AUTOCRINE MECHANISM. HEPATOLOGY, 14(4), A110. |
| 1991 | AHMED, Q., JOHNSON, S. J., HINES, J. E., & BURT, A. D. (1991). IMMUNOHISTOCHEMICAL LOCALIZATION OF PERISINUSOIDAL (ITO) CELLS IN HUMAN LIVER. JOURNAL OF PATHOLOGY, 163(2), A177. |
| 1991 | LEE, J. A., AHMED, Q., HINES, J. E., & BURT, A. D. (1991). ALTERATIONS OF HEPATIC SINUSOIDAL INNERVATION IN LIVER-DISEASE. JOURNAL OF PATHOLOGY, 163(2), A178. |
| 1991 | Griffiths, M. R., Keir, S., & Burt, A. D. (1991). Basement membrane proteins in the space of Disse: A reappraisal. Journal of Clinical Pathology, 44(8), 646-648. Scopus28 WoS27 Europe PMC20 |
| 1991 | MURPHY, E., GRIFFITHS, M. R., HUNTER, J. A., & BURT, A. D. (1991). Fibrin‐ring granulomas: a non‐specific reaction to liver injury?. Histopathology, 19(1), 91-93. Scopus26 WoS9 Europe PMC7 |
| 1991 | JOHNSON, S. J., HINES, J. E., & BURT, A. D. (1991). PROLIFERATION OF PERISINUSOIDAL (ITO) CELLS FOLLOWING ACUTE LIVER-INJURY. JOURNAL OF PATHOLOGY, 163(2), A170. |
| 1991 | GRIFFITHS, M. R., SCHUPPAN, D., MACSWEEN, R. N. M., FERRIER, R., & BURT, A. D. (1991). LOCALIZATION OF TYPE-VI COLLAGEN IN NORMAL AND FIBROTIC LIVER. JOURNAL OF PATHOLOGY, 163(2), A178. |
| 1990 | RAWEILY, E. A., GIBSON, A. A. M., & BURT, A. D. (1990). Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia. Histopathology, 17(6), 521-527. Scopus71 WoS51 Europe PMC37 |
| 1990 | MYSZOR, M., TURNER, I., MITCHISON, H., BENNETT, M., BURT, A. D., & JAMES, O. F. W. (1990). NO SYMPTOMATIC OR HISTOLOGICAL BENEFIT FROM URSODEOXYCHOLIC ACID TREATMENT IN PBC AFTER 1 YEAR CONTROLLED PILOT-STUDY. HEPATOLOGY, 12(2), 415. WoS8 |
| 1990 | MOWAT, A., ALLISON, M. C., BURT, A. D., MILLS, P. R., BRIGGS, J. D., & MACSWEEN, R. N. M. (1990). CHRONIC LIVER-DISEASE IN RENAL-TRANSPLANT RECIPIENTS. JOURNAL OF PATHOLOGY, 160(2), A169. |
| 1990 | RAWEILY, E. A., GIBSON, A. A., & BURT, A. D. (1990). INTRAHEPATIC CHOLANGIOPATHY IN EXTRAHEPATIC BILIARY ATRESIA. JOURNAL OF PATHOLOGY, 160(2), A164. |
| 1990 | BURT, A. D., GRIFFITHS, M. R., SCHUPPAN, D., VOSS, B., & MACSWEEN, R. N. M. (1990). Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno‐gold labelling. Histopathology, 16(1), 53-58. Scopus32 WoS34 Europe PMC25 |
| 1989 | Burt, A. D., Tiniakos, D., MacSween, R. N. M., Griffiths, M. R., Wisse, E., & Polak, J. M. (1989). Localization of adrenergic and neuropeptide tyrosine‐containing nerves in the mammalian liver. Hepatology, 9(6), 839-845. Scopus62 WoS58 Europe PMC52 |
| 1989 | Goudie, B. M., Macfarlane, G. J., Boyle, P., Gillis, C. R., MacSween, R. N. M., & Watkinson, G. (1989). Risk Factors and Prognosis in Primary Biliary Cirrhosis. The American Journal of Gastroenterology, 84(7), 713-716. Scopus68 WoS64 Europe PMC45 |
| 1989 | Hillan, K. J., Burt, A. D., George, W. D., Macsween, R. N. M., Griffiths, M. R., & Bradley, J. A. (1989). Intrasplenic hepatocyte transplantation in rats with experimental liver injury: Morphological and morphometric studies. Journal of Pathology, 159(1), 67-73. Scopus33 WoS34 Europe PMC24 |
| 1989 | BURT, A. D., GRIFFITHS, M. R., SCHUPPAN, D., VOSS, B., & MACSWEEN, R. N. M. (1989). LOCALIZATION OF TYPE-IV COLLAGEN IN HUMAN-LIVER USING IMMUNOELECTRON MICROSCOPY. JOURNAL OF PATHOLOGY, 157(2), A174. |
| 1989 | Geerts, A., Vrijsen, R., Rauterberg, J., Burt, A., Schellinck, P., & Wisse, E. (1989). In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. Journal of Hepatology, 9(1), 59-68. Scopus178 WoS200 Europe PMC137 |
| 1988 | KERR, D. J., REED, N., MACFARLANE, G. J., BOYLE, P., & BURT, A. D. (1988). THE INFLUENCE OF TREATMENT ON SURVIVAL FROM WELL DIFFERENTIATED THYROID-CARCINOMA. BRITISH JOURNAL OF CANCER, 58(2), 272. |
| 1988 | BURT, A. D., GRIFFITHS, M., MACSWEEN, R. N. M., SCHUPPAN, D., & VOSS, B. (1988). IDENTIFICATION OF EXTRACELLULAR-MATRIX PROTEINS IN HUMAN-LIVER BIOPSIES USING AN IMMUNOGOLD TECHNIQUE. HEPATOLOGY, 8(5), 1302. |
| 1988 | BURT, A. D., GRIFFITHS, M., POLAK, J. M., & MACSWEEN, R. N. M. (1988). PEPTIDERGIC INNERVATION OF THE MAMMALIAN LIVER. HEPATOLOGY, 8(5), 1295. WoS1 |
| 1988 | Verhoeven, D., Buyssens, N., Burt, A. D., & Macsween, R. N. M. (1988). Letters to the editor. Journal of Pathology, 154(3), 287-288. Scopus1 Europe PMC1 |
| 1988 | HILLAN, K. J., BURT, A. D., MACSWEEN, R. N. M., GEORGE, W. D., & BRADLEY, J. A. (1988). INTRASPLENIC HEPATOCYTE TRANSPLANTATION IN ANIMALS WITH EXPERIMENTAL LIVER-INJURY. HEPATOLOGY, 8(5), 1440. |
| 1988 | BURT, A. D., & MACSWEEN, R. N. M. (1988). DESMIN-CONTAINING STELLATE CELLS IN THE RAT-LIVER - REPLY. JOURNAL OF PATHOLOGY, 154(3), 288. |
| 1988 | GRIFFITHS, M., BURT, A. D., & MACSWEEN, R. N. M. (1988). LOCALIZATION OF EXTRACELLULAR-MATRIX PROTEINS IN HUMAN-LIVER BY IMMUNO-ELECTRON MICROSCOPY. JOURNAL OF PATHOLOGY, 154(1), A78. |
| 1988 | HILLAN, K. J., BURT, A. D., BRADLEY, J. A., GEORGE, W. D., & MACSWEEN, R. N. M. (1988). INTRASPLENIC HEPATOCYTE TRANSPLANTATION IN EXPERIMENTAL LIVER-INJURY - MORPHOMETRICAL AND MORPHOLOGICAL-STUDIES. JOURNAL OF PATHOLOGY, 154(1), A77. |
| 1987 | GOUDIE, B. M., MACFARLANE, G., BOYLE, P., BURT, A. D., GILLIS, C. R., MACSWEEN, R. N. M., & WATKINSON, G. (1987). EPIDEMIOLOGY OF ANTIMITOCHONDRIAL ANTIBODY SEROPOSITIVITY AND PRIMARY BILIARY-CIRRHOSIS IN THE WEST OF SCOTLAND. GUT, 28(10), A1346. WoS12 |
| 1987 | BURT, A. D., TINIAKOS, D., MACSWEEN, R. N. M., & POLAK, J. M. (1987). LOCALIZATION OF NEUROPEPTIDE Y CONTAINING NORADRENERGIC NERVES IN MAMMALIAN LIVER. JOURNAL OF PATHOLOGY, 151(1), A67. |
| 1987 | HILLAN, K. J., BURT, A. D., MACSWEEN, R. N. M., GEORGE, W. D., & BRADLEY, J. A. (1987). TRANSPLANTATION OF ISOLATED HEPATOCYTES INTO ANIMALS WITH EXPERIMENTAL LIVER-INJURY. JOURNAL OF HEPATOLOGY, 5, S144. |
| 1987 | BURT, A. D., GILLON, M., WISSE, E., POLAK, J. M., & MACSWEEN, R. N. M. (1987). DISTRIBUTION OF CALCITONIN GENE RELATED PEPTIDE (CGRP) AND SUBSTANCE P-CONTAINING NERVES IN LIVER - AN IMMUNOHISTOCHEMICAL STUDY. GUT, 28(10), A1330. WoS3 |
| 1987 | Kerr, D. J., Burt, A. D., & Anderson, J. R. (1987). Tumours of the diffuse endocrine system. European Journal of Surgical Oncology, 13(3), 189-195. Scopus6 WoS4 Europe PMC3 |
| 1987 | MacSween, R. N. M., Burt, A. D., & Haboubi, N. Y. (1987). Unusual variant of primary sclerosing cholangitis. Journal of Clinical Pathology, 40(5), 541-545. Scopus5 WoS7 Europe PMC5 |
| 1987 | Burt, A. D., Seywright, M. M., & George, W. D. (1987). Mixed apocrine-medullary carcinoma of the breast. Report of a case with fine needle aspiration cytology. Acta Cytologica, 31(3), 322-324. Scopus8 WoS7 Europe PMC3 |
| 1987 | Burt, A. D., MacGuire, J., Lindop, G. B., & Browne, M. K. (1987). Mixed follicular-parafollicular carcinoma of the thyroid. Scottish Medical Journal, 32(2), 50-51. Scopus6 WoS3 Europe PMC3 |
| 1987 | Burt, A. D., Stewart, J. A., Aitchison, M., & Macsween, R. N. M. (1987). Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: Changes in liver disease. Journal of Clinical Pathology, 40(7), 719-724. Scopus28 WoS24 Europe PMC18 |
| 1987 | Burt, A. D., Cooper, G., MacKay, C., & Boyd, J. F. (1987). Dermoid cyst of the testis. Scottish Medical Journal, 32(5), 146-148. Scopus12 WoS6 Europe PMC7 |
| 1987 | CONNELL, J. M. C., CORDER, R., ASBURY, J., MACPHERSON, S., INGLIS, G. C., LOWRY, P., . . . SEMPLE, P. F. (1987). NEUROPEPTIDE Y IN MULTIPLE ENDOCRINE NEOPLASIA: RELEASE DURING SURGERY FOR PHAEOCHROMOCYTOMA. Clinical Endocrinology, 26(1), 75-84. Scopus12 WoS12 Europe PMC10 |
| 1987 | BURT, A. D., STEWART, J., & MACSWEEN, R. N. M. (1987). IMMUNOLOCALIZATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) IN HUMAN-LIVER BIOPSIES. JOURNAL OF PATHOLOGY, 151(1), A67. |
| 1987 | HILLAN, K. J., BURT, A. D., GEORGE, W. D., & BRADLEY, J. A. (1987). FAILURE OF HEPATOCYTE TRANSPLANTATION TO IMPROVE SURVIVAL IN AN EXPERIMENTAL-MODEL OF CHRONIC LIVER-INJURY. JOURNAL OF HEPATOLOGY, 5, S144. |
| 1986 | BURT, A. D., TINIAKOS, D., MACSWEEN, R. N. M., & POLAK, J. M. (1986). NEUROPEPTIDE TYROSINE (NPY) IMMUNOREACTIVITY IN INTRAHEPATIC NERVES IN RAT AND HUMAN-LIVER. JOURNAL OF PATHOLOGY, 148(1), A67. |
| 1986 | Goudie, B. M., Burt, A. D., Macfarlane, G., Birnie, G. G., Macsween, R. N. M., & Watkinson, G. (1986). Breast cancer in women with primary biliary cirrhosis. British Medical Journal Clinical Research Ed, 292(6516), 341. |
| 1986 | Burt, A. D., & MacSween, R. N. M. (1986). Hepatic vein lesions in alcoholic liver disease: Retrospective biopsy and necropsy study. Journal of Clinical Pathology, 39(1), 63-67. Scopus68 WoS37 Europe PMC28 |
| 1986 | Burt, A. D., Robertson, J. L., Heir, J., & Macsween, R. N. M. (1986). Desmin‐containing stellate cells in rat liver; distribution in normal animals and response to experimental acute liver injury. Journal of Pathology, 150(1), 29-35. Scopus113 WoS118 Europe PMC84 |
| 1986 | Kerr, D. J., Burt, A. D., Boyle, P., MacFarlane, G. J., Storer, A. M., & Brewin, T. B. (1986). Prognostic factors in thyroid tumours. British Journal of Cancer, 54(3), 475-482. Scopus38 WoS40 Europe PMC27 |
| 1986 | GOUDIE, B. M., BURT, A. D., MACFARLANE, G., BIRNIE, G. G., MACSWEEN, R. N. M., WATKINSON, G., . . . GILLIS, C. R. (1986). BREAST-CANCER IN WOMEN WITH PRIMARY BILIARY-CIRRHOSIS - REPLY. BRITISH MEDICAL JOURNAL, 292(6516), 340-341. Europe PMC1 |
| 1986 | Hollman, A. S., Morley, P., Burt, A. D., & Davidson, J. K. (1986). Biliary tract dilatation in acquired immune deficiency syndrome. European Journal of Radiology, 6(4), 309-310. Scopus1 WoS4 Europe PMC1 |
| 1986 | MacSween, R. N. M., & Burt, A. D. (1986). Histologic spectrum of alcoholic liver disease. Seminars in Liver Disease, 6(3), 221-232. Scopus226 WoS190 Europe PMC154 |
| 1986 | Burt, A. D., Smillie, D., Cowan, M. D., & Adams, F. G. (1986). Fine needle aspiration cytology: experience with a cell block technique.. Journal of Clinical Pathology, 39(1), 114-115. Scopus16 WoS19 Europe PMC12 |
| 1986 | Kerr, D. J., Burt, A. D., Beastall, G. H., & Holloway, C. D. (1986). The effect of 5-fluorouracil on rat adrenal function. Medical Oncology and Tumor Pharmacotherapy, 3(2), 101-104. Scopus1 WoS1 Europe PMC1 |
| 1986 | ROBERTSON, J. L., BURT, A. D., & MACSWEEN, R. N. M. (1986). MORPHOMETRICAL STUDY OF DESMIN-CONTAINING NONPARENCHYMAL CELLS IN EXPERIMENTAL ACUTE LIVER-INJURY. JOURNAL OF PATHOLOGY, 148(1), A66. |
| 1986 | BURT, A. D., STEWART, J., & MACSWEEN, R. N. M. (1986). IMMUNOLOCALIZATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) IN HUMAN-LIVER BIOPSIES. HEPATOLOGY, 6(4), 802. |
| 1986 | GOUDIE, B. M., BURT, A. D., MACFARLANE, G., BOYLE, P., MACSWEEN, R. M. N., WATKINSON, G., & GILLIS, C. R. (1986). FACTORS AFFECTING THE PROGNOSIS OF PRIMARY BILIARY-CIRRHOSIS. DIGESTIVE DISEASES AND SCIENCES, 31(10), S476. |
| 1986 | PLUMB, J. A., WILMOTT, N., KERR, D. J., BURT, A. D., MORE, I. A. R., & KAYE, S. B. (1986). FLUORESCENT MICROSCOPIC STUDIES ON THE DIFFERENTIAL CELLULAR-DISTRIBUTION OF ADRIAMYCIN AND 4'-DEOXYDOXORUBICIN. BRITISH JOURNAL OF CANCER, 53(3), 440. |
| 1986 | BURT, A. D., ROBERTSON, J. L., & MACSWEEN, R. N. M. (1986). IDENTIFICATION OF DESMIN-CONTAINING NONPARENCHYMAL CELLS IN RAT-LIVER. JOURNAL OF PATHOLOGY, 148(1), A65-A66. |
| 1986 | GOUDIE, B. M., BURT, A. D., MACFARLANE, G., BOYLE, P., MACSWEEN, R. N. M., GILLIS, C. R., & WATKINSON, G. (1986). THE NATURAL-HISTORY OF PRIMARY BILIARY-CIRRHOSIS. SCOTTISH MEDICAL JOURNAL, 31(1), 60. |
| 1985 | BURT, A. D., & MACSWEEN, R. N. M. (1985). VENO-OCCLUSIVE LESIONS IN ALCOHOLIC LIVER-DISEASE. JOURNAL OF PATHOLOGY, 145(1), A87. |
| 1985 | BURT, A. D., BROWN, I. L., KERR, D. J., & BOYLE, P. (1985). IMMUNOHISTOCHEMICAL DEMONSTRATION OF EPITHELIAL AND LYMPHOID MARKERS IN ANAPLASTIC THYROID-TUMORS. SCOTTISH MEDICAL JOURNAL, 30(1), 56. |
| 1985 | BURT, A. D., KERR, D. J., BROWN, I. L., & BOBROW, L. G. (1985). HISTOGENESIS OF ANAPLASTIC THYROID-TUMORS. BRITISH JOURNAL OF CANCER, 52(3), 447-448. |
| 1985 | Burt, A. D., Kerr, D. J., Brown, I. L., & Boyle, P. (1985). Lymphoid and epithelial markers in small cell anaplastic thyroid tumours. Journal of Clinical Pathology, 38(8), 893-896. Scopus18 WoS19 Europe PMC11 |
| 1985 | Kerr, D. J., Burt, A. D., Brewin, T. B., & Boyle, P. (1985). DIVERGENCE BETWEEN MORTALITY AND INCIDENCE RATES OF THYROID CANCER IN SCOTLAND. Lancet, 326(8447), 149. Scopus7 WoS9 Europe PMC4 |
| 1985 | MacSween, R. N. M., & Burt, A. D. (1985). The cellular pathology of primary biliary cirrhosis. Molecular Aspects of Medicine, 8(3), 269-291. Scopus15 WoS12 Europe PMC12 |
| 1985 | Goudie, B. M., Burt, A. D., Macfarlane, G., Birnie, G. G., Mills, P. R., Macsween, R. N. M., . . . Gillis, C. R. (1985). Breast cancer in women with primary biliary cirrhosis. British Medical Journal Clinical Research Ed, 291(6509), 1597-1598. Scopus58 WoS54 Europe PMC47 |
| 1984 | Burt, A. D., & Goudie, R. B. (1984). Thyroglobulin in carcinoma of the thyroid. Human Pathology, 15(2), 197-198. Scopus3 WoS4 Europe PMC3 |
| 1984 | Burt, A. D., Scott, G., Shiach, C. R., & Isles, C. G. (1984). Acquired immunodeficiency syndrome in a patient with no known risk factors: A pathological study. Journal of Clinical Pathology, 37(4), 471-474. Scopus19 WoS25 Europe PMC16 |
| 1984 | Behan, W. M. H., & Burt, A. D. (1984). HTLV-III SEROPOSITIVITY IN AIDS. Lancet, 323(8389), 1292. Scopus1 WoS2 Europe PMC1 |
| 1984 | Shiach, C. R., Burt, A. D., Isles, C. G., & Ball, S. G. (1984). Pyrexia of undetermined origin, diarrhoea, and primary cerebral lymphoma associated with acquired immunodeficiency. British Medical Journal, 288(6415), 449-450. Scopus11 WoS7 Europe PMC7 |
| 1984 | BURT, A. D., BROWN, I. L., STEWART, J., & KERR, D. J. (1984). IMMUNOHISTOCHEMICAL STUDY OF ANAPLASTIC SMALL CELL TUMORS OF THYROID. JOURNAL OF PATHOLOGY, 143(4), A296. |
| 1982 | Burt, A. D., Anthony, R. S., Hislop, W. S., Bouchier, I. A., & MacSween, R. N. (1982). Liver membrane antibodies in alcoholic liver disease: I. Prevalence and immunoglobulin class. Gut, 23(3), 221-225. Scopus40 WoS37 Europe PMC25 |
| 1981 | MacSween, R., Burt, A., Anthony, R., & Hislop, W. (1981). Liver membrane antibodies in alcoholic liver disease. Journal of Pathology, 134(4), 332. |
| 1980 | Burt, A., MacSween, R. N. M., Galbraith, I., & Hislop, W. S. (1980). Liver membrane antibodies in alcoholic liver disease. Scottish Medical Journal, 25(2), 163-164. Scopus5 |
| 1979 | BURT, A., & GOUDIE, R. B. (1979). Diagnosis of primary thyroid carcinoma by immunohistological demonstration of thyroglobulin. Histopathology, 3(4), 279-286. Scopus69 WoS78 Europe PMC55 |
| Year | Citation |
|---|---|
| 2023 | Burt, A., Ferrell, L. D., & Hübscher, S. G. (2023). MacSween's Pathology of the Liver, Eighth Edition. Elsevier. DOI Scopus2 |
| 2018 | Burt, A. D., Ferrell, L. D., & Hübscher, S. G. (Eds.) (2018). MacSween's Pathology of the Liver (7 ed.). Scopus30 |
| 2018 | Burt, A. D., Ferrell, L. D., & Hübscher, S. G. (Eds.) (2018). MacSween's Pathology of the Liver (7 ed.). Scopus30 |
| 2011 | Burt, A. D., Portmann, B. C., & Ferrell, L. D. (2011). Preface. DOI |
| 2011 | Burt, A. D., Portmann, B. C., & Ferrell, L. D. (Eds.) (2011). MacSween's pathology of the liver (6 ed.). Churchill Livingstone/Elsevier. DOI Scopus73 |
| 2011 | Burt, A. D., Portmann, B. C., & Ferrell, L. D. (Eds.) (2011). MacSween's pathology of the liver (6 ed.). Churchill Livingstone/Elsevier. DOI Scopus73 |
| Year | Citation |
|---|---|
| 2023 | Bellamy, C. O. C., & Burt, A. D. (2023). Liver in Systemic Disease. In Macsween S Pathology of the Liver Eighth Edition (pp. 1039-1095). Elsevier. DOI |
| 2023 | Tiniakos, D. G., Anstee, Q. M., Brunt, E. M., & Burt, A. D. (2023). Fatty Liver Disease. In Macsween S Pathology of the Liver Eighth Edition (pp. 330-401). Elsevier. DOI Scopus6 |
| 2018 | Tiniakos, D. G., Anstee, Q. M., & Burt, A. D. (2018). Fatty Liver Disease. In A. D. Burt, L. D. Ferrell, & S. G. Hubscher (Eds.), MacSween's Pathology of the Liver (7 ed., pp. 308-371). Elsevier. DOI Scopus23 |
| 2018 | Burt, A. D., Ferrell, L. D., & Hübscher, S. G. (2018). Preface. In A. D. Burt, L. D. Ferrell, & S. G. Hubscher (Eds.), MacSween's Pathology of the Liver (7 ed., pp. v-vi). Elselvier. DOI Scopus7 |
| 2018 | Bellamy, C., & Burt, A. D. (2018). The Liver in Systemic Disease. In A. D. Burt, L. D. Ferrell, & S. G. Hubscher (Eds.), MacSween's Pathology of the Liver (7 ed., pp. 966-1018). Elsevier. DOI Scopus8 |
| 2012 | Burt, A. D., Portmann, B. C., & Ferrell, L. D. (2012). Preface. In A. D. Burt, B. C. Portmann, & L. D. Ferrell (Eds.), MacSween's pathology of the liver (6 ed., pp. xi). Elsevier. DOI |
| 2011 | Brunt, E. M., Neuschwander-Tetri, B. A., & Burt, A. D. (2011). Fatty Liver Disease: Alcoholic and Non-Alcoholic. In Macsween S Pathology of the Liver Expert Consult Online and Print (pp. 293-359). Elsevier. DOI Scopus35 |
| 2011 | Quaglia, A., Burt, A. D., Ferrell, L. D., & Portmann, B. C. (2011). Systemic Disease. In Macsween S Pathology of the Liver Expert Consult Online and Print (pp. 935-986). Elsevier. DOI Scopus3 |
| 2011 | Crawford, J. M., & Burt, A. D. (2011). Anatomy, Pathophysiology and Basic Mechanisms of Disease. In Macsween S Pathology of the Liver Expert Consult Online and Print (pp. 1-77). Elsevier. DOI Scopus29 |
| Year | Citation |
|---|---|
| 2023 | McNeil, C., Wong, P. F., Sridhar, N., Wang, Y., Santori, C., Wu, C. H., . . . Cimermancic, P. (2023). AI-enabled virtual hematoxylin and eosin and Masson's trichrome staining for non-alcoholic fatty liver disease activity scoring from single unstained slide. In JOURNAL OF HEPATOLOGY Vol. 78 (pp. S671-S672). ELSEVIER. |
| 2022 | Vacca, M., Kamzolas, I., Harder, L. M., Oakley, F., Trautwein, C., Hatting, M., . . . Vidal-Puig, A. (2022). Is there a murine model that fully recapitulates human NASH? An unbiased bioinformatics approach to rank pre-clinical models based on proximity to human disease. In JOURNAL OF HEPATOLOGY Vol. 77 (pp. S7-S8). ELSEVIER. WoS1 |
| 2022 | Mauricio, J., Murphy, S., McCain, M., Geh, D., Kadharusman, M., Leslie, J., . . . Reeves, H. L. (2022). Hepatocellular carcinoma and neutrophils-towards understanding positive and negative impacts on treatments and progression. In JOURNAL OF HEPATOLOGY Vol. 77 (pp. S646-S647). ELSEVIER. |
| 2022 | Burt, A. D., Carey, C., Jones, C., Ness, T., Coulthard, R., Bennick, L., . . . Kirkness, M. (2022). Collagen Hybridising Peptides Reliably Detect Total and Degraded Collagen in Human Liver Biopsies and May Provide Prognostic Information. In JOURNAL OF PATHOLOGY Vol. 256 (pp. S11). ELECTR NETWORK: WILEY. |
| 2021 | Van Haele, M., Younes, R., Cockell, S., Palmer, J., Ostyn, T., Wouters, J., . . . Govaere, O. (2021). Pro-inflammatory hepatic progenitor cell response is associated with progression of human non-alcoholic fatty liver disease. In JOURNAL OF HEPATOLOGY Vol. 75 (pp. S266). ELSEVIER. |
| 2020 | Govaere, O., McPherson, S., Younes, R., Tiniakos, D., Pais, R., Bedossa, P., . . . Anstee, Q. (2020). A transcriptomic signature predicting fibrosis progression in a large European cohort of patients with histologically characterised NAFLD. In JOURNAL OF HEPATOLOGY Vol. 73 (pp. S109-S110). ELSEVIER. |
| 2020 | Cottingham, S. W., Mauricio-Muir, J., McCain, M. V., Watson, R., Evans, C., Wilson, C., . . . Reeves, H. (2020). ELEVATED NUMBERS AND SIZE OF AGGREGATES OF IMMUNE CELLS PROTECTS AGAINST LIVER CANCER PROGRESSION. In GUT Vol. 69 (pp. A38). ELECTR NETWORK: BMJ PUBLISHING GROUP. DOI |
| 2020 | Mauricio-Muir, J., McCain, M., Watson, R., Masson, S., McPherson, S., Burt, A., . . . Reeves, H. L. (2020). ELEVATED INTRATUMOUR NEUTROPHILS ASSOCIATE WITH IMPROVED TREATMENT RESPONSES AND PROGNOSIS IN PATIENTS WITH HCC. In GUT Vol. 69 (pp. A32). ELECTR NETWORK: BMJ PUBLISHING GROUP. DOI |
| 2019 | Tian, Y., Pu, L. Z. C. T., Singh, R., Burt, A. D., & Carneiro, G. (2019). One-stage five-class polyp detection and. In 2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI) Vol. 2019-April (pp. 70-73). online: IEEE. DOI Scopus29 WoS17 |
| 2018 | Pu, L. Z. C. T., Campbell, B., Burt, A. D., Carneiro, G., & Singh, R. (2018). COMPUTER-AIDED DIAGNOSIS FOR CHARACTERISING COLORECTAL LESIONS: INTERIM RESULTS OF A NEWLY DEVELOPED SOFTWARE. In GASTROINTESTINAL ENDOSCOPY Vol. 87 (pp. AB245). Washington, DC: MOSBY-ELSEVIER. WoS4 |
| 2018 | Pu, L. Z. C. T., Lu, K., Ovenden, A., Edwards, S., Wilson, B., Carneiro, G., . . . Singh, R. (2018). EFFECT OF TRAINING AND TIME OF THE DAY ON POLYP DETECTION RATES IN AUSTRALIA. In GASTROINTESTINAL ENDOSCOPY Vol. 87 (pp. AB161). Washington, DC: MOSBY-ELSEVIER. |
| 2018 | Pu, L. Z. C. T., Koay, D. S., Ovenden, A., Singh, G., Rana, K., Burt, A. D., & Singh, R. (2018). OPTICAL EVALUATION OF SCARS AFTER EMR USING NBI WITH DUAL FOCUS AND UNDERWATER TECHNIQUE (UNBI-DF): INTERIM ANALYSIS. In GASTROINTESTINAL ENDOSCOPY Vol. 87 (pp. AB377). Washington, DC: MOSBY-ELSEVIER. |
| 2017 | Pu, L. Z. C. T., Koay, D. S. C., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study to evaluate scars after colorectal endoscopic mucosal resection using narrow-band imaging with dual focus and underwater technique: Interim analysis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 33-34). WILEY. |
| 2017 | Pu, L. Z. C. T., Campbell, B., Carneiro, G., Burt, A. D., & Singh, R. (2017). Computer-aided diagnosis (CAD) for characterizing colorectal lesions: Initial results of newly developed software. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 34-35). WILEY. |
| 2017 | Pu, L. Z. C. T., Koay, D. S. C., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study predicting histology in colorectal lesions: Interim analysis of the NICE, JNET, and MS classifications. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 34). WILEY. |
| 2015 | Wahed, S., Disep, B., Peace, R., Burt, A., & Griffin, M. (2015). Minimally Invasive Sentinel Lymph Node Biopsy in Oesophageal Adenocarcinoma. In BRITISH JOURNAL OF SURGERY Vol. 102 (pp. 4). Manchester, ENGLAND: WILEY-BLACKWELL. |
| 2013 | Tanwar, S., Parkes, J., Hogan, B. J., Schuppan, D., Pinzani, M., Arthur, M. J. P., . . . Rosenberg, W. M. (2013). FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. In GUT Vol. 62 (pp. A188). Glasgow, SCOTLAND: BMJ PUBLISHING GROUP. DOI |
| 2013 | Tanwar, S., Parkes, J., Trembling, P. M., Hogan, B. J., Schuppan, D., Pinzani, M., . . . Rosenberg, W. M. (2013). FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S550). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI |
| 2013 | Liu, Y. -L., Patman, G., Leathart, J., Burt, A., Day, C. P., Daly, A. K., . . . Anstee, Q. M. (2013). CARRIAGE OF PNPLA3 I148M IS ASSOCIATED WITH AN INCREASED RISK OF NON-ALCOHOLIC FATTY LIVER DIESEASE ASSOCIATED HEPATOCELLULAR CARCINOMA. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S516). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI WoS8 |
| 2013 | Brain, J., Masson, S., & Burt, A. (2013). TRANSPLANTATION FOR ALD: LESSONS FROM THE EXPLANT. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S213). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI |
| 2013 | Anstee, Q. M., Darlay, R., Leathart, J., Liu, Y. -L., Tordjman, J., Clement, K., . . . Day, C. P. (2013). A CANDIDATE-GENE APPROACH TO VALIDATION OF GENETIC MODIFIER ASSOCIATIONS USING A LARGE COHORT WITH HISTOLOGICALLY CHARACTERISED NON-ALCOHOLIC FATTY LIVER DISEASE. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S46). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI WoS10 |
| 2013 | Bedossa, P., Gouw, A., Lackner, C., Schirmacher, P., Terraciano, L., Tiniakos, D., & Burt, A. (2013). APPLICATION, UTILITY AND VALIDATION OF A NEW HISTOLOGICAL SYSTEM FOR CLASSIFICATION OF NAFLD IN PATIENTS WITH METABOLIC SYNDROME. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S33). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI |
| 2013 | Brain, J., Thompson, E., Jones, D., Burt, A., & Kirby, J. (2013). Transplantation: Do Senescence and Autophagy Modulate the Development of Chronic Pathology.. In AMERICAN JOURNAL OF TRANSPLANTATION Vol. 13 (pp. 505). Seattle, WA: WILEY-BLACKWELL. |
| 2012 | Tanwar, S., Trembling, P. M., Thorburn, D., Guha, I. N., Parkes, J., Kaye, P., . . . Rosenberg, W. M. (2012). DIRECT SERUM MARKERS ARE MORE ACCURATE THAN SIMPLE MARKER PANELS FOR THE DETECTION OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). In GUT Vol. 61 (pp. A414). B M J PUBLISHING GROUP. DOI |
| 2012 | Masson, S., Emmerson, I., Henderson, E., Fletcher, E., Burt, A., Day, C., & Stewart, S. (2012). CLINICAL BUT NOT HISTOLOGICAL FACTORS PREDICT LONG-TERM PROGNOSIS IN PATIENTS WITH BIOPSY PROVEN ADVANCED ALCOHOLIC LIVER DISEASE. In GUT Vol. 61 (pp. A413-A414). Liverpool, ENGLAND: B M J PUBLISHING GROUP. DOI WoS1 |
| 2012 | Robinson, S., Wilson, C., Burt, A., Manas, D., & White, S. (2012). CHEMOTHERAPY ASSOCIATED LIVER INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS. In GUT Vol. 61 (pp. A357). B M J PUBLISHING GROUP. DOI |
| 2012 | Robinson, S., Mann, J., Manas, D., Burt, A., Mann, D., & White, S. (2012). AN EXPERIMENTAL STUDY TO DETERMINE THE PATHOGENESIS OF OXALIPLATIN INDUCED SINUSOIDAL OBSTRUCTION SYNDROME. In GUT Vol. 61 (pp. A26). B M J PUBLISHING GROUP. DOI |
| 2012 | McPherson, S., Griffiths, L., Hardy, T., Henderson, E., Burt, A., Day, C., & Anstee, Q. M. (2012). THE FIB-4 SCORE RELIABLY EXCLUDES ADVANCED FIBROSIS IN A DIABETIC COHORT WITH NAFLD. In JOURNAL OF HEPATOLOGY Vol. 56 (pp. S515-S516). Barcelona, SPAIN: ELSEVIER SCIENCE BV. DOI WoS1 |
| 2012 | Tanwar, S., Trembling, P. M., Thorburn, D., Guha, I. N., Parkes, J., Kaye, P., . . . Rosenberg, W. M. (2012). DIRECT SERUM MARKERS ARE MORE ACCURATE THAN SIMPLE MARKER PANELS FOR THE DETECTION OF FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD). In JOURNAL OF HEPATOLOGY Vol. 56 (pp. S423). Barcelona, SPAIN: ELSEVIER SCIENCE BV. |
| 2011 | Prentis, J., McPherson, S., Burt, A., Manas, D., Snowden, C., Hudson, M., & Masson, S. (2011). PRE-TRANSPLANT HISTOLOGICAL ASSESSMENT IN PATIENTS WITH ALCOHOLIC LIVER DISEASE DOES NOT PREDICT RISK OF RECIDIVISM POST LIVER TRANSPLANTATION. In GUT Vol. 60 (pp. A37-A38). BMJ PUBLISHING GROUP. DOI |
| 2011 | Tanwar, S., Trembling, P., Guha, I. N., Parkes, J., Kaye, P., Burt, A. D., . . . Rosenberg, W. M. (2011). VALIDATION OF A NOVEL BIOMARKER MODEL FOR THE PREDICTION OF NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. In GUT Vol. 60 (pp. A4-A5). BMJ PUBLISHING GROUP. DOI |
| 2011 | McPherson, S., Anstee, Q., Henderson, E., Burt, A., & Day, C. (2011). ARE SIMPLE NON-INVASIVE SCORING SYSTEMS FOR FIBROSIS RELIABLE IN PATIENTS WITH NAFLD AND NORMAL ALT LEVELS?. In GUT Vol. 60 (pp. A54-A55). BMJ PUBLISHING GROUP. DOI |
| 2011 | Leavitt, M., Burt, A. D., Hu, W., Canty, D., Gray, M., Bray, A., . . . Quinn, A. G. (2011). RECOMBINANT LYSOSOMAL ACID LIPASE NORMALIZES LIVER WEIGHT, TRANSAMINASES AND HISTOPATHOLOGICAL ABNORMALITIES IN AN <i>IN VIVO</i> MODEL OF CHOLESTERYL ESTER STORAGE DISEASE. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S358). Berlin, GERMANY: ELSEVIER. DOI WoS12 |
| 2011 | Robinson, S. M., Mann, J., Burt, A. D., Manas, D. M., Mann, D. A., & White, S. A. (2011). Pathogenesis of chemotherapy associated liver injury prior to major hepatic resection. In BRITISH JOURNAL OF SURGERY Vol. 98 (pp. 20). Royal Coll Surgery, Dublin, IRELAND: WILEY-BLACKWELL. |
| 2011 | Wallace, K., Shaw, J., White, S. A., Wright, S., Burt, A. D., & Wright, M. C. (2011). PROLONGED GLUCOCORTICOID EXPOSURE RESULTS IN THE APPEARANCE OF HEPATOCYTES IN THE ADULT PANCREAS. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S435). Berlin, GERMANY: ELSEVIER. |
| 2011 | Tanwar, S., Trembling, P. M., Guha, I. N., Parkes, J., Kaye, P., Burt, A. D., . . . Rosenberg, W. M. (2011). VALIDATION OF A NOVEL BIOMARKER MODEL FOR THE PREDICTION OF NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. In HEPATOLOGY Vol. 54 (pp. 1123A). San Francisco, CA: WILEY-BLACKWELL. |
| 2011 | Jennings, N. A., Burt, A. D., & Griffin, S. M. (2011). Lymph node metastases in early oesophageal adenocarcinoma. In BRITISH JOURNAL OF SURGERY Vol. 98 (pp. 91). Bournemouth, ENGLAND: WILEY-BLACKWELL. |
| 2011 | Zeybel, M., Oakley, F., Burt, A. D., Mann, D. A., & Mann, J. (2011). PROTECTIVE ADAPTATION TO LIVER FIBROSIS IN A SINGLE GENERATION BY HERITABLE EPIGENETIC MODIFICATIONS. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S52-S53). Berlin, GERMANY: ELSEVIER. DOI |
| 2011 | Koshy, A., Knisely, A., Robinson, S. M., White, S., & Burt, A. D. (2011). Bile Canalicular Protein Expression is Altered in Chemotherapy-induced Sinusoidal Obstruction Syndrome (SOS). In JOURNAL OF PATHOLOGY Vol. 224 (pp. S37). Univ Ghent, Dept Pathol, Onderbergen, BELGIUM: WILEY-BLACKWELL. |
| 2011 | Brain, J., Burt, A. D., Kirby, J. A., & Robertson, H. (2011). Investigation of the Fate of Cholangiocytes in Cholestatic Liver Disease. In JOURNAL OF PATHOLOGY Vol. 224 (pp. S22). Univ Cambridge, Dept Pathol, Cambridge, ENGLAND: WILEY-BLACKWELL. |
| 2011 | McPherson, S., Anstee, Q. M., Henderson, E., Burt, A. D., & Day, C. P. (2011). ARE SIMPLE NON-INVASIVE SCORING SYSTEMS FOR FIBROSIS RELIABLE IN PATIENTS WITH NAFLD AND NORMAL ALT LEVELS?. In HEPATOLOGY Vol. 54 (pp. 1125A). San Francisco, CA: WILEY-BLACKWELL. WoS1 |
| 2010 | Mann, J., Oakley, F., Burt, A. D., Tsukamoto, H., & Mann, D. (2010). EPIGENETIC REGULATION OF PRO-FIBROGENIC GENES INVOLVED IN HEPATIC STELLATE CELL ACTIVATION AND LIVER FIBROSIS. In HEPATOLOGY Vol. 52 (pp. 1267A). Boston, MA: WILEY-BLACKWELL. |
| 2010 | Chakraborty, J. B., Mann, J., Oakley, F., Burt, A. D., & Mann, D. A. (2010). NF-KB1 (P50) PROTECTS AGAINST GROWTH OF HEPATOCELLULAR CARCINOMA BY SUPPRESSING ROS, INHIBITING HEPATIC PHOSPHOSTAT3 AND STIMULATING PHOSPHOP38α. In HEPATOLOGY Vol. 52 (pp. 593A). Boston, MA: WILEY-BLACKWELL. |
| 2010 | Wright, M. C., Wallace, K., Shaw, J. A., Burt, A. D., & White, S. A. (2010). Long term glucocorticoid therapy leads to pancreatic acinar trans-differentiation into hepatocyte-like cells. In BRITISH JOURNAL OF SURGERY Vol. 97 (pp. 28). Royal Free Hosp, London, ENGLAND: JOHN WILEY & SONS LTD. |
| 2010 | White, S. A., Shaw, J. A., Flecknell, P. A., Burt, A. D., & Wright, M. C. (2010). Chronic elevated systemic glucocorticoid results in widespread pancreatic-hepatic trans-differentiation <i>in vivo</i>. In TOXICOLOGY Vol. 278 (pp. 347). Herriot Watt Univ, Edinburgh, ENGLAND: ELSEVIER IRELAND LTD. DOI |
| 2009 | Mann, J., Xu, X., Oakley, F., Maxwell, A., Elsharkawy, A. M., Mann, D. A., & Burt, A. D. (2009). EPIGENETICALLY INHERITED RESISTANCE TO LIVER FIBROSIS. In HEPATOLOGY Vol. 50 (pp. 849A-850A). Boston, MA: JOHN WILEY & SONS INC. WoS2 |
| 2009 | McGee, K. C., Harte, A. L., Hill, M. J., Burt, A. D., Kumar, S., Day, C. P., & McTernan, P. G. (2009). Circulating visfatin levels reduced in patients with non-alcoholic fatty liver disease irrespective of type 2 diabetes mellitus status. In DIABETOLOGIA Vol. 52 (pp. S20-S21). Vienna, AUSTRIA: SPRINGER. |
| 2009 | Al-Rifai, A., Henderson, E., De Alwis, N., Burt, A. D., Day, C. P., & Stewart, S. (2009). STEATOSIS AND INFLAMMATION ARE TOGETHER ASSOCIATED WITH FIBROSIS PROGRESSION IN PATIENTS WITH NASH. In HEPATOLOGY Vol. 50 (pp. 802A). Boston, MA: JOHN WILEY & SONS INC. |
| 2009 | Wallace, K., White, S. A., Shaw, J. A., Burt, A. D., & Wright, M. C. (2009). CHRONIC ELEVATED SYSTEMIC GLUCOCORTICOCOID RESULTS IN WIDESPREAD PANCREATIC-HEPATIC TRANS-DIFFERENTIATION IN VIVO. In HEPATOLOGY Vol. 50 (pp. 899A). Boston, MA: JOHN WILEY & SONS INC. |
| 2009 | Gieling, R. G., Rajasekaran, V., Jurk, D., Elsharkawy, A. M., Burt, A. D., Oakley, F., & Mann, D. A. (2009). THE ANTI-INFLAMMATORY AND ANTI-PROLIFERATIVE PROPERTIES OF THE NFKB1 (P50) GENE PROTECT AGAINST HEPATOCELLULAR CARCINOMA. In HEPATOLOGY Vol. 50 (pp. 881A). Boston, MA: JOHN WILEY & SONS INC. |
| 2008 | Marshall, H. L., Robertson, H., Burt, A. D., Jones, D. E. J., Kirby, J. A., & Hudson, M. (2008). Biliary epithelial to mesenchymal transition contributes to portal tract fibrogenesis in primary sclerosing cholangitis. In GUT Vol. 57 (pp. A50-A51). Brimingham, ENGLAND: B M J PUBLISHING GROUP. |
| 2008 | Elsharkawy, A. M., Gieling, R. G., Oakley, F., Kendall, T., Burt, A. D., & Mann, D. A. (2008). Attenuated inflammatory response in fibrotic livers of mice lacking the c-Rel subunit of NF-kB. In JOURNAL OF HEPATOLOGY Vol. 48 (pp. S22-S23). Milan, ITALY: ELSEVIER SCIENCE BV. DOI |
| 2008 | Kendrick, S., Leathart, J. B., Henderson, E., De Alwis, N., Stewart, S., Burt, A. D., . . . Day, C. P. (2008). A 'LOSS-OF-FUNCTION' MUTATION IN TIRAP, THE GENE ENCODING THE TOLL-LIKE RECEPTOR ADAPTER MOLECULE MAL PROTECTS AGAINST FIBROSIS IN NAFLD BUT NOT ALD. In HEPATOLOGY Vol. 48 (pp. 334A-335A). San Francisco, CA: JOHN WILEY & SONS INC. WoS1 |
| 2007 | Newton, J. L., Jones, D. E., Kane, L., Henderson, E., Pairman, J., Wilton, K., . . . Day, C. P. (2007). Fatigue in NAFLD is severe and associates with excessive daytime somnolence but not with liver disease severity or insulin resistance. In HEPATOLOGY Vol. 46 (pp. 742A-743A). Boston, MA: JOHN WILEY & SONS INC. |
| 2007 | van der Laan, L. J. W., Thomas, R. C., Zondervan, P. E., Lindsay, A. S., Burt, A. D., Hudson, M., . . . Metselaar, H. J. (2007). The effect of calcineurin inhibitor usage on hepatic fibrosis progression in HCV-positive liver transplant recipients: A two-centre study.. In LIVER TRANSPLANTATION Vol. 13 (pp. S152). Rio de Janeiro, BRAZIL: JOHN WILEY & SONS INC. WoS1 |
| 2006 | Price, D. A., Donaldson, P. T., Ann, D. K., Leathart, J. B., Burt, A. D., Schmid, M. L., & Bassendine, M. F. (2006). Microsomal triglyceride transfer protein gene promoter polymorphism (493g allele) is associated with severity of hcv-associated steatosis.. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S151). Paris, FRANCE: ELSEVIER SCIENCE BV. DOI |
| 2006 | Rygiel, K. A., Robertson, H., Burt, A. D., Jones, D. E. J., & Kirby, J. A. (2006). Demonstration of the transition of intrahepatic biliary epithelial cells to fibroblasts during chronic inflammatory liver diseases. In JOURNAL OF HEPATOLOGY Vol. 44 (pp. S241). Vienna, AUSTRIA: ELSEVIER SCIENCE BV. DOI WoS7 |
| 2006 | Price, D. A., Burt, A. D., Schmid, M. L., Craig, W. L., & Bassendine, M. F. (2006). Steatosis in chronic HCV infection: viral and host characteristics. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S127-S128). Paris, FRANCE: ELSEVIER SCIENCE BV. DOI |
| 2006 | Price, D. A., Schmid, M. L., Agarwal, K., Hewett, M., Craig, W. L., Burt, A. D., & Bassendine, M. F. (2006). Chronic hepatitis C in injecting drug users: a comparison with non-injecting drug users in the same geographic area. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S212). Paris, FRANCE: ELSEVIER SCIENCE BV. DOI |
| 2005 | Robertson, H., Xu, X., Burt, A. D., & Kirby, J. A. (2005). Epithelial to mesenchymal transition in chronic cholestatic liver disease. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 30). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD. WoS1 |
| 2005 | Burt, A. D. (2005). Vascular tumours. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 58). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD. |
| 2005 | El-Refaie, A. M. A., Agarwal, K., & Burt, A. D. (2005). Ductular reaction in early post-transplant liver biopsies: effects of immunosuppression. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 29). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD. |
| 2005 | El-Refaie, A. A., & Burt, A. D. (2005). Ductular reaction in the post-transplanted liver: a component of cellular rejection. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 2). London, ENGLAND: JOHN WILEY & SONS LTD. |
| 2005 | Nielsen, S. U., Burt, A. D., Martin, C., Bassendine, M. F., & Toms, G. L. (2005). Human hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral-particles. In ATHEROSCLEROSIS Vol. 182 (pp. S6-S7). Univ Glamorgan, Pontypridd, WALES: ELSEVIER IRELAND LTD. |
| 2005 | Zhao, L., Robertson, H., Kirby, J. A., Jones, D. E. J., & Burt, A. D. (2005). Epithelial-mesenchymal transition in portal fibrosis. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 1). London, ENGLAND: JOHN WILEY & SONS LTD. |
| 2005 | Xu, X., Bulmer, J. N., & Burt, A. D. (2005). Mast cells in human decidua and trophoblast: alternations in placental pathology. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 5). London, ENGLAND: JOHN WILEY & SONS LTD. |
| 2005 | Malcolm, P., Mathew, J., Walker, M., & Burt, A. D. (2005). Distinctive pattern of liver histology in poorly controlled type I diabetes. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 29). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD. |
| 2005 | Nielsen, S. U., Burt, A. D., Martin, C., Bassendine, M., & Toms, G. (2005). Hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral particles. In HEPATOLOGY Vol. 42 (pp. 563A). San Francisco, CA: JOHN WILEY & SONS INC. |
| 2005 | Stark, F., Smith, D., & Burt, A. D. (2005). Pathogenesis of peribiliary gland hamartomas revisited. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 17). London, ENGLAND: JOHN WILEY & SONS LTD. |
| 2004 | Price, D. A., Bassendine, M. F., Gouldin, C., Norris, S., Toms, G. L., Schmid, M. L., . . . Donaldson, P. T. (2004). Apolipoprotein E2 protects against persistent hepatitis C virus infection.. In HEPATOLOGY Vol. 40 (pp. 445A). Boston, MA: JOHN WILEY & SONS INC. |
| 2004 | Stewart, S. F., Jones, D. E. J., Vidali, M., Haugk, B., Burt, A. D., Albano, E., & Day, C. P. (2004). Correlation between anti-CYP2E1 titre and lymphocyte infiltration in ALD - An autoimmune disease in some patients?. In JOURNAL OF HEPATOLOGY Vol. 40 (pp. 176-177). Berlin, GERMANY: ELSEVIER SCIENCE BV. DOI WoS4 |
| 2004 | Price, D. A., Burt, A. D., Turner, A., Craig, W. L., Schmid, M. L., & Bassendine, M. F. (2004). Host and viral characteristics associated with steatosis in chronic hepatitis C. In GUT Vol. 53 (pp. A82-A83). Glasgow, Scotland: B M J PUBLISHING GROUP. |
| 2004 | Zhao, L., & Burt, A. D. (2004). Expansion of hepatic stellate cell populations occurs in response to primary and metastatic liver tumours. In JOURNAL OF PATHOLOGY Vol. 204 (pp. 8A). Vrije Univ Med Ctr, Dept Pathol, Amstedram, NETHERLANDS: JOHN WILEY & SONS LTD. |
| 2003 | Stewart, S. F., Daly, A. K., Chen, Y., Leathart, J. B., Haugk, B., Jones, D. E. J., . . . Day, C. P. (2003). Evidence that alcoholic liver disease is due to immune mechanisms in genetically susceptible drinkers. In GUT Vol. 52 (pp. 2 pages). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP. |
| 2003 | Nielson, S. U., Burt, A. D., Martin, C., Bassendine, M. F., & Toms, G. L. (2003). Association of HCV particles with LDL/VLDL: Analysis using isotonic iodixanol gradient centrifugation & real time PCR.. In HEPATOLOGY Vol. 38 (pp. 670A-671A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO. |
| 2003 | Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., . . . Day, C. P. (2003). Oxidative stress is an independent risk factor for the progression of non-alcoholic fatty liver disease (NAFLD) to advanced fibrosis.. In HEPATOLOGY Vol. 38 (pp. 506A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO. |
| 2003 | Hicks, A. E. R., Burt, A. D., Thompson, M. G., & Day, C. P. (2003). Bile acids have a direct effect on collagen biosynthesis by hepatic stellate cells. In GUT Vol. 52 (pp. 2 pages). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP. |
| 2003 | Zhao, L., & Burt, A. D. (2003). Neural and muscle proteins in hepatic stellate cells and mesenchymal cells of other mammalian tissues. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 22A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD. |
| 2003 | Igbokwe, U. O., Gould, D. J., Burt, A. D., & Mathew, J. (2003). Methotrexate, psoriasis and α<sub>1</sub>-antitrypsin deficiency:: a cocktail for liver fibrosis?. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 20A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD. |
| 2003 | El-Refaie, A. M. A., & Burt, A. D. (2003). Mast cells in liver allograft rejection. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 22A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD. |
| 2003 | Leong, M. Y., Burt, A. D., Gould, D. J., Bowers, P. W., & Mathew, J. (2003). Haemochromatosis and methotrexate: inviting liver fibrosis?. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 20A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD. |
| 2003 | Price, D. A., Agawal, K., Hewett, M., Craig, W. L., Schmid, M., Turner, A., . . . Bassendine, M. F. (2003). The hepatitis C virus (HCV) epidemic; spectrum of chronic liver disease in a single UK centre. In GUT Vol. 52 (pp. 1 page). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP. |
| 2003 | Saksena, S., Leathart, J. B., Burt, A. D., James, O. F. W., Daly, A. K., & Day, C. P. (2003). Genetic evidence supporting the two-hit model of NASH pathogenesis. In GUT Vol. 52 (pp. 1 page). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP. |
| 2002 | Crompton, D. E., Chinnery, P. F., Fey, C., Curtis, A. R. J., Morris, C. M., Kierstan, J., . . . Burn, J. (2002). Neuroferritinopathy: A window on the role of iron in neurodegeneration. In Blood Cells Molecules Diseases Vol. 29 (pp. 522-531). CHIEMESEE, GERMANY: ACADEMIC PRESS INC ELSEVIER SCIENCE. DOI Scopus74 WoS65 Europe PMC54 |
| 2002 | Hicks, A. E., Burt, A. D., Thompson, M. G., & Day, C. P. (2002). Bile acids have a direct effect on collagen biosynthesis by hepatic stellate cells.. In HEPATOLOGY Vol. 36 (pp. 485A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO. |
| 2002 | Price, A., Agawal, K., Hewett, M., Craig, W. L., Schmid, M., Turner, A., . . . Bassendine, M. F. (2002). The hepatitis C virus (HCV) epidemic; Spectrum of chronic liver disease in a single UK centre.. In HEPATOLOGY Vol. 36 (pp. 554A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO. |
| 1997 | Dack, C. L., Day, C. P., Johnson, S. J., & Burt, A. D. (1997). Population kinetics of GFAP-positive cells following experimental acute liver injury. In E. Wisse, D. L. Knook, & C. Balabaud (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 6 (pp. 59-61). BORDEAUX, FRANCE: KUPFFER CELL FOUNDATION. WoS2 |
| 1997 | Reeves, H. L., Dack, C. L., Day, C. P., & Burt, A. D. (1997). β<sub>1</sub> Integrin expression in hepatic stellate cells from normal and diseased human livers. In E. Wisse, D. L. Knook, & C. Balabaud (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 6 (pp. 154-155). BORDEAUX, FRANCE: KUPFFER CELL FOUNDATION. WoS2 |
| 1994 | BURT, A. D., & MATHEW, J. (1994). CELL-CELL AND CELL-MATRIX INTERACTIONS IN HEPATOCARCINOGENESIS. In G. Tiniakos (Ed.), PROGRESS IN HEPATOLOGY '94 (pp. 73-80). ATHENS, GREECE: BETA MEDICAL PUBLISHERS LTD. WoS1 |
| 1993 | HINES, J. E., & BURT, A. D. (1993). EXPRESSION OF CELLULAR INTEGRINS AND THEIR LIGANDS IN HUMAN LIVER SINUSOIDS DURING ONTOGENY. In D. L. Knook, & E. Wisse (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 4 (pp. 574-577). KUPFFER CELL FDN, ANTWERP, BELGIUM: KUPFFER CELL FOUNDATION. WoS1 |
| 1993 | MATHEW, J., & BURT, A. D. (1993). CELLULAR MECHANISMS OF FIBROGENESIS IN GENETIC HEMOCHROMATOSIS. In D. L. Knook, & E. Wisse (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 4 (pp. 274-276). KUPFFER CELL FDN, ANTWERP, BELGIUM: KUPFFER CELL FOUNDATION. WoS1 |
| 1992 | MATHEW, J., JAMES, O. F. W., HINES, J. E., & BURT, A. D. (1992). QUANTITATIVE-ANALYSIS OF THE PERISINUSOIDAL CELL AND MACROPHAGE RESPONSE TO ACETAMINOPHEN-INDUCED LIVER-INJURY. In A. M. GRESSNER, & G. RAMADORI (Eds.), MOLECULAR AND CELL BIOLOGY OF LIVER FIBROGENESIS (pp. 358-360). MARBURG, GERMANY: KLUWER ACADEMIC PUBL. WoS1 |
| 1992 | JOHNSON, S. J., HILLAN, K. J., HINES, J. E., FERRIER, R., & BURT, A. D. (1992). PROLIFERATION AND PHENOTYPIC MODULATION OF PERISINUSOIDAL (ITO) CELLS FOLLOWING ACUTE LIVER-INJURY - TEMPORAL RELATIONSHIP WITH TGF-BETA-1 EXPRESSION. In B. CLEMENT, & A. GUILLOUZO (Eds.), CELLULAR AND MOLECULAR ASPECTS OF CIRRHOSIS Vol. 216 (pp. 219-222). RENNES, FRANCE: INSERM / JOHN LIBBEY EUROTEXT. WoS10 |
| 1991 | BURR, A. W., JOHNSON, S. J., CARPENTER, M. R., & BURT, A. D. (1991). IMMUNOLOCALIZATION OF TRANSFORMING GROWTH FACTOR-ALPHA (TGF-ALPHA) IN REGENERATING LIVER FOLLOWING CHEMICALLY-INDUCED NECROSIS. In K. W. WOODHOUSE, & M. S. OMAHONY (Eds.), DRUG METABOLISM, LIVER INJURY AND AGEING Vol. 16 (pp. 203-210). CARDIFF, WALES: EURAGE BOOK SERVICE. |
| 1991 | AHMED, Q., HINES, J. E., HARRISON, D., & BURT, A. D. (1991). EXPRESSION OF MUSCLE-ASSOCIATED CYTOSKELETAL PROTEINS BY HUMAN SINUSOIDAL LIVER-CELLS. In E. WISSE, D. L. KNOOK, & R. S. MCCUSKEY (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 3 (pp. 203-206). TUCSON, AZ: KUPFFER CELL FOUNDATION. WoS5 |
| 1991 | GRIFFITHS, M. R., FERRIER, R., SCHUPPAN, D., & BURT, A. D. (1991). COLLAGEN TYPE-VI - A COMPONENT OF THE PERISINUSOIDAL EXTRACELLULAR-MATRIX IN HUMAN LIVER. In E. WISSE, D. L. KNOOK, & R. S. MCCUSKEY (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 3 (pp. 155-160). TUCSON, AZ: KUPFFER CELL FOUNDATION. |
| 1991 | MATHEW, J., WYNNE, H., CATTAN, A. R., HALL, A. G., & BURT, A. D. (1991). EXPRESSION OF GLUTATHIONE S-TRANSFERASES IN THE AGING LIVER. In K. W. WOODHOUSE, & M. S. OMAHONY (Eds.), DRUG METABOLISM, LIVER INJURY AND AGEING Vol. 16 (pp. 173-180). CARDIFF, WALES: EURAGE BOOK SERVICE. |
| 1991 | HINES, J. E., JOHNSON, S. J., & BURT, A. D. (1991). NONPARENCHYMAL CELL RESPONSES DURING THE DEVELOPMENT OF BILIARY-CIRRHOSIS. In K. W. WOODHOUSE, & M. S. OMAHONY (Eds.), DRUG METABOLISM, LIVER INJURY AND AGEING Vol. 16 (pp. 211-217). CARDIFF, WALES: EURAGE BOOK SERVICE. |
| 1991 | BURT, A. D., AHMED, Q., HINES, J. E., & LEE, J. A. (1991). INNERVATION OF HUMAN HEPATIC SINUSOIDS - ALTERATIONS IN LIVER-DISEASE. In E. WISSE, D. L. KNOOK, & R. S. MCCUSKEY (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 3 (pp. 92-97). TUCSON, AZ: KUPFFER CELL FOUNDATION. WoS2 |
| 1986 | GOUDIE, B. M., BURT, A. D., MACFARLANE, G., BOYLE, P., MACSWEEN, R. N. M., & WATKINSON, G. (1986). FACTORS AFFECTING THE PROGNOSIS OF PRIMARY BILIARY-CIRRHOSIS. In GUT Vol. 27 (pp. A622). BRITISH MED JOURNAL PUBL GROUP. |
| Year | Citation |
|---|---|
| 2019 | Pu, L. Z. C. T., Chiam, K., Yamamura, T., Nakamura, M., Berzin, T., Mir, F., . . . Singh, R. (2019). Narrow-band imaging for scar (NBI-SCAR) classification: From conception to multicenter validation. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. WoS1 |
| 2018 | Pu, L. Z. C. T., Yamamura, T., Nakamura, M., Koay, D. S. C., Ovenden, A., Edwards, S., . . . Singh, R. (2018). Prospective study predicting histology in colorectal lesions using wNICE, wJNET, and MS classifications. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2018 | Pu, L. Z. C. T., Ovenden, A., Nakamura, M., Yamamura, T., Sawada, T., Koay, D. S. C., . . . Singh, R. (2018). Prospective study assessing associated factors in patients with colorectal lesions. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2018 | Pu, L. Z. C. T., Lu, K., Ovenden, A., Rana, K., Singh, G., Krishnamurthi, S., . . . Singh, R. (2018). Effect of training and time of the day on polyp detection rates. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2018 | Pu, L. Z. C. T., Singh, G., Krishnamurthi, S., Ovenden, A., Nakamura, M., Yamamura, T., . . . Singh, R. (2018). Prevalence and distribution of serrated polyps in the colon. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2017 | Houghton, D., Zalewski, P., Cassidy, S., Thoma, C., Hallsworth, K., Avery, L., . . . Trenell, M. I. (2017). Autonomic function is impaired across the spectrum of NAFLD. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI |
| 2017 | Pu, L., Koay, D., Ovenden, A., Burt, A., & Singh, R. (2017). Prospective study assessing associated factors in patients with colon polyps: Interim analysis. Poster session presented at the meeting of Abstracts of the annual scientific meeting of the Gastroenterological Society of Australia, Australian Gastroenterology Week (GESA AGW 2017), as published in Journal of Gastroenterology and Hepatology. Gold Coast, QLD: Wiley. DOI |
| 2017 | Cheng, L. Z. T. P., Siew, D. C. K., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study to evaluate scars after colorectal EMR using NBI with dual focus and underwater technique (uNBI-DF): Interim analysis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2017 | Cheng, L. Z. T. P., Campbell, B., Carneiro, G., Burt, A. D., & Singh, R. (2017). Computer-aided diagnosis (CAD) for characterising colorectal lesions: Initial results of a newly developed software. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2017 | Cheng, L. Z. T. P., Siew, D. C. K., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study predicting histology in colorectal lesions: Interim analysis of the NICE, JNET and MS classifications. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. WoS1 |
| 2017 | Cheng, L. Z. T. P., Siew, D. C. K., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study assessing associated factors in patients with colon polyps: interim analysis. Poster session presented at the meeting of Abstracts of the Asian Pacific Digestive Week (APDW). The Future in Digestive Diseases, as published in Journal of Gastroenterology and Hepatology. Hong Kong: Wiley. DOI WoS1 |
| 2015 | Mcpherson, S., Hardy, T., Henderson, E., Allison, M., Ratziu, V., Francque, S., . . . Anstee, Q. M. (2015). HIGH RATE OF FALSE POSITIVES FOR ADVANCED FIBROSIS WHEN SIMPLE NON-INVASIVE FIBROSIS TESTS ARE USED IN OLDER PATIENTS (≥ 65 YEARS) WITH NAFLD. Poster session presented at the meeting of GUT. London, ENGLAND: BMJ PUBLISHING GROUP. DOI WoS1 |
| 2014 | McPherson, S., Henderson, E., Hardy, T., Burt, A. D., Day, C., & Anstee, Q. M. (2014). Natural history of NAFLD: A study of 108 patients with paired liver biopsies. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL. |
| 2013 | Patman, G. L., Televantou, D., Whitehead, A., Day, C. P., Oakley, F., Mann, D. A., . . . Reeves, H. L. (2013). MILD STEATOSIS AND IMPAIRED GLUCOSE TOLERANCE ARE ASSOCIATED WITH LIVER CANCER DEVELOPMENT, WHILE PROGRESSION TO NASH INCREASES NUMBER/SIZE IN AN ANIMAL MODEL OF NAFLD. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI |
| 2013 | Brain, J. G., Masson, S., & Burt, A. D. (2013). Transplantation for ALD: Lessons From the Explant. Poster session presented at the meeting of JOURNAL OF PATHOLOGY. Univ Edinburgh, Div Pathol, Edinburgh, SCOTLAND: WILEY-BLACKWELL. |
| 2013 | Patman, G. L., Televantou, D., Whitehead, A., Piguet, A. -C., Dufour, J. F., Day, C. P., . . . Reeves, H. L. (2013). SULFATASE-2 (SULF2) EXPRESSED IN HEPATOCYTES AND STROMAL CELLS CONTRIBUTES TO THE DEVELOPMENT OF STEATOSIS, THE PROGRESSION OF NAFLD TO FIBROSIS AND THE ADVANCEMENT OF CANCER. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI |
| 2013 | Whitehead, A., Patman, G. L., Cornell, L., Televantou, D., Curtin, N., Day, C. P., . . . Reeves, H. L. (2013). A ROLE FOR DNA REPAIR PROTEIN KINASE (DNA-PK) IN THE PROGRESSION OF SIMPLE STEATOSIS TO STEATOHEPATITIS (NASH)?. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI |
| 2013 | Probert, P. M. E., Ebrahimkhani, M. R., Oakley, F., Burt, A. D., Mann, D. A., & Wright, M. C. (2013). METHAPYRILENE TREATMENT IS A REFINED ALTERNATIVE TO BILE DUCT LIGATION AS A MODEL OF REPRODUCIBLE AND REVERSIBLE PERIPORTAL FIBROSIS IN THE RAT. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER. DOI |
| 2013 | Rutkowski, J. V., Burt, A. D., Leavitt, M. C., Hu, W., Canty, D., & Quinn, A. G. (2013). Co-localization of macrophage aggregation and fibrosis in a rat model of lysosomal acid lipase (LAL) deficiency and the effects of enzyme replacement with SBC-102. Poster session presented at the meeting of MOLECULAR GENETICS AND METABOLISM. Orlando, FL: ACADEMIC PRESS INC ELSEVIER SCIENCE. DOI WoS2 |
| 2012 | Trembling, P. M., Parkes, J., Tanwar, S., Burt, A. D., & Rosenberg, W. M. (2012). ENHANCED LIVER FIBROSIS TEST ACCURATELY IDENTIFIES LIVER FIBROSIS AND PREDICTS CLINICAL OUTCOMES IN ALCOHOLIC LIVER DISEASE. Poster session presented at the meeting of GUT. B M J PUBLISHING GROUP. DOI |
| 2012 | Rutkowski, J., Burt, A. D., Leavitt, M., Hu, W., Canty, D., & Quinn, A. G. (2012). Recombinant Human Lysosomal Acid Lipase Decreases Hepatic Macrophage Aggregates and Colocalized Fibrosis in a Rat Model of Lysosomal Acid Lipase Deficiency. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL. WoS3 |
| 2012 | Robinson, S. M., Mann, J., Burt, A. D., Manas, D. M., Mann, D. A., & White, S. A. (2012). Does a pro-thrombotic environment contribute to the development of chemotherapy associated liver injury in patients with colorectal liver metastases?. Poster session presented at the meeting of Abstracts from the Annual Meeting of the Society of Academic and Research Surgery, as published in British Journal of Surgery. Nottingham, England: WILEY-BLACKWELL. DOI |
| 2012 | Televantou, D., Hui, K. Y. D., Lochan, R., Charnley, R., Burt, A. D., & Reeves, H. L. (2012). MEMBRANOUS EXPRESSION OF SULFATASE-2 IS ASSOCIATED WITH A POORER PROGNOSIS IN PATIENTS FOLLOWING PANCREATIC CANCER RESECTION. Poster session presented at the meeting of GUT. B M J PUBLISHING GROUP. DOI |
| 2012 | Tanwar, S., Trembling, P. M., Hogan, B. J., Thorburn, D., Guha, I. N., Parkes, J., . . . Rosenberg, W. M. (2012). An algorithm combining direct and indirect liver fibrosis tests enhances diagnostic performance for the detection of advanced fibrosis (F3-4) in NAFLD minimising the need for liver biopsy. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL. WoS1 |
| 2012 | Robinson, S. M., Koshy, A., Knisely, A., Manas, D. M., Burt, A. D., & White, S. A. (2012). Biliary dysfunction in patients with sinusoidal obstruction syndrome. Poster session presented at the meeting of Abstracts from the Annual Meeting of the Society of Academic and Research Surgery, as published in British Journal of Surgery. Nottingham, England: Wiley-Blackwell. DOI |
| 2012 | Masson, S., Emmerson, I., Henderson, E., Fletcher, E., Burt, A. D., Day, C. P., & Stewart, S. F. (2012). Clinical but not histological factors predict long-term prognosis in patients with biopsy proven advanced alcoholic liver disease. Poster session presented at the meeting of Abstracts of The International Liver Congress™ 2012 – 47th annual meeting of the European Association for the Study of the Liver, as published in Journal of Hepatology. Barcelona, Spain: Elsevier Ireland. DOI |
| 2012 | Brain, J. G., Thompson, E., Burt, A. D., & Kirby, J. A. (2012). Allografts, Immunosupression and Autophagy: A Conspiracy to Fibrose?. Poster session presented at the meeting of JOURNAL OF PATHOLOGY. Univ Sheffield, Acad Unit Pathol, Sheffield, ENGLAND: WILEY-BLACKWELL. |
| 2012 | Trembling, P. M., Parkes, J., Tanwar, S., Burt, A. D., & Rosenberg, W. M. (2012). Enhanced liver fibrosis test accurately identifies liver fibrosis and predicts clinical outcomes in alcoholic liver disease. Poster session presented at the meeting of Abstracts of The International Liver Congress™ 2012 – 47th annual meeting of the European Association for the Study of the Liver, as published in Journal of Hepatology. Barcelona, Spain: Elsevier Ireland. DOI WoS2 |
| 2012 | Anstee, Q. M., Darlay, R., Leathart, J. B., Clement, J., Clement, K., Aithal, G. P., . . . Day, C. P. (2012). Genome-Wide Association Analysis Confirms Importance of PNPLA3 and Identifies Novel Variants Associated With Histologically Progressive Steatohepatitis in NAFLD. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL. WoS7 |
| 2012 | Dunn, L. J., Shenfine, J., Burt, A. D., Jankowski, J. A., & Griffin, S. M. (2012). Columnar metaplasia in the oesophageal remnant following oesophagectomy - a common occurrence and a valuable insight into the development of Barrett's oesophagus. Poster session presented at the meeting of Abstracts from the International Surgical Congress of the Association-of-Surgeons-of-Great-Britain-and-Ireland (ASGBI),as published in British Journal of Surgery. Liverpool, ENGLAND: Wiley-Blackwell. DOI |
| 2012 | Robinson, S. M., Mann, J., Manas, D. M., Burt, A. D., Mann, D. A., & White, S. A. (2012). An experimental model of FOLFOX-induced sinusoidal obstruction syndrome.. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. United States: AMER SOC CLINICAL ONCOLOGY. DOI |
| 1994 | BURT, A. D., HILLAN, K. J., MCLAUGHLIN, K. E., CHAPMAN, C., MATHEW, J., & BURR, A. W. (1994). HEPATOCYTE GROWTH-FACTOR LEVELS IN LIVER AND SERUM INCREASE DURING CHEMICAL HEPATOCARCINOGENESIS. Poster session presented at the meeting of HEPATOLOGY. W B SAUNDERS CO. |
| 1992 | Lee, J. A., Boon, A. P., Hubscher, S. G., Hines, J. E., & Burt, A. D. (1992). Hepatic reinnervation following orthotopic liver transplantation in man. Poster session presented at the meeting of Journal of Physiology. CAMBRIDGE UNIV PRESS. |
| Year | Citation |
|---|---|
| 2021 | Tian, Y., Pu, L. Z. C. T., Liu, Y., Maicas, G., Verjans, J. W., Burt, A. D., . . . Carneiro, G. (2021). Detecting, Localising and Classifying Polyps from Colonoscopy Videos using Deep Learning.. |
| Date | Grant | Amount |
|---|---|---|
| October 1986 | Scottish Home and Health Department Grant K/MRS/50/C956 - Extracellular matrix protein synthesis in the human liver | £56,000 |
| November 1986 | Tenovus (Scotland) - The role of sinusoidal cells in protein biosynthesis by the mammalian liver | £10,000 |
| November 1986 | Kinnear Brown Trust - Towards purchase of Beckman JE-6B elutriator rotor centrifuge | £11,000 |
| July 1988 | Scottish Home and Health Department Biomedical Research Committee Extracellular matrix protein synthesis in the liver | £26,000 |
| December 1989 | Newcastle Health Authority Research Committee - Role of transforming growth factor in the response of fat strong cells to liver injury and the induction of experimental hepatic fibrosis | £13,976 |
| April 1990 | North of England Cancer Research Campaign - Cellular origin of hepatocyte growth factor in liver regeneration and during hepatocarcinogenesis | £46,896 |
| May 1990 | University Research Committee - Production of monoclonal antibodies to rat liver perisinusoidal cells | £6,635 |
| August 1990 | Newcastle University Hospital Special Trustees - Intracellular ion measurements for the investigation of cellular pathology | £35,566 |
| September 1990 | University (Small Grants) Awards - Localisation of peptide growth factors in normal and fibrotic human liver | £658 |
| March 1991 | Newcastle Health Authority Research Committee - Alterations to intra-hepatic nerves in chronic liver disease and orthotopic liver allografts | £15,133 |
| May 1991 | North of England Cancer Research Campaign - Cell-matrix interactions in hepato- carcinogenesis | £37,550 |
| July 1991 | North of England Cancer Research Campaign - DNA repair by O6-methyl guanine DNA methyl transferase: its role in human hepatocarcinogenesis | £104,058 |
| November 1992 | North of England Cancer Research Campaign - Modulation of cell proliferation in vivo using monoclonal anti-growth factor antibodies | £78,697 |
| November 1992 | Northern Regional Health Authority - Quantitative assessment of hepatic fibrosis in percutaneous liver biopsy specimens | £16,079 |
| June 1993 | University Hospital Special Trustees - Risk stratification in hereditary non-polyposis colorectal cancer | £30,647 |
| August 1993 | University Hospitals Trustees -Integrins and cadherins as prognostic indicators in breast cancer | £18,100 |
| February 1994 | MRC Clinical Training Fellowship (for Dr. S. Hinchliffe) - Expression of androgen receptor in human malignancies: molecular pathological studies |
£33,075 |
| April 1994 | Northern Regional Health Authority - In situ PCR: application to hepatitis C virus infection | £25,000 |
| April 1994 | Wellbeing/Royal College of Obstetricians and Gynaecologists - The pulmonary interstitium in normal development and bronchopulmonary dysplasia |
£23,594 |
| June 1994 | Medical Research Council Collaborative PhD Studentship - Modulation of the function of hepatocyte growth factor and its receptor in vivo using antibodies to recombinant proteins | £35,000 |
| June 1994 | Luccock Faculty Studentship - Cell-matrix interactions and signal transduction pathways in liver perisinusoidal (Ito) cells | £24,000 |
| May 1995 | North of England Cancer Research Campaign - Alkylation DNA damage and repair | £71,000 |
| June 1995 | British Lung Foundation - Cell proliferation and programmed cell death in the early human lung development | £21,720 |
| June 1995 | University Hospital Special Trustees - Endothelin 1 and endothelin receptors in alcoholic liver disease | £21,000 |
| July 1995 | National Institute of Health (USA) (with Dr JN Bulmer) - Preterm labor: an immune phenomenon? | £48,000 |
| February 1996 | Freeman Hospital Trustees - Endothelial damage after liver perfusion | £1,718 |
| February 1996 | Bayer Pharmaceuticals - In vivo inhibition of growth factor activity following injury: image bullets and fibrogenesis | £34,700 |
| January 1998 | Bayer Pharmaceuticals -Serum markers of liver fibrosis | £109,889 |
| July 1998 | National Kidney Research Fund - Renal allograft rejection: examination of the basis for tissue specific cytotoxicity | £75,000 |
| January 1999 | University Hospital Special Trustees - Cell signalling in hepatic stellate cells: role of lipid second messengers | £9,700 |
| February 1999 | Harker Foundation - Bile duct destruction in autoimmune cholangiopathy | £37,500 |
| June 2000 | Wellcome Trust- Biochemical and functional characterisation of hepatitis C virus particles isolated from human liver and serum | £163,593 |
| August 2000 | William Harker Foundation - Do apoptotic biliary epithelial cells provide the antigen for induction of autoimmune cholangiopathy? | £53,876 |
| August 2001 | Cancer Research Campaign - Lymphatic mapping and sentinel node biopsy in the evaluation of the metastatic dissemination of oesophageal adenocarcinoma | £43,169 |
| February 2001 | Children’s Liver Disease Foundation - The role of bile acids in the regulation of hepatic stellate cell function | £75,067 |
| April 2001 | Medical Research Council - Use of multiple epidemiological methods to examine clues to environmental causative factors in primary biliary cirrhosis | £128,221 |
| December 2002 |
Newcastle Healthcare Charity - Novel mechanisms of progressive allograft dysfunction |
£9,100 |
| June 2003 | Roche Organ Transplant Research Foundation - Therapeutic elimination of intraepithelial T cells: a strategy to reduce epithelial-mesenchymal transdifferentiation and chronic allograft dysfunction | £125,424 |
| January 2004 | National Association for Crohn’s Disease and Colitis - Histological correlation with genetic variation in Crohn’s disease |
£38,000 |
| February 2007 | National Kidney Research Fund - Kidney allograft failure: implications of the imbalance between IL-17 and TGFβ producing intratubular cells | £112,070 |
| April 2008 | Newcastle Healthcare Charity - Pilot study of the use of antibody to surface proteins on hepatic myofibroblasts in fibrosis imaging | £24,725 |
| October 2008 | Wellcome Trust - Role of myofibroblasts in liver injury and regeneration | £263,000 |
| January 2009 | European Commission FP7 - INFLA-CARE Understanding inflammation associated for the rational decision of novel anti-cancer | 554,592 euros |
| July 2009 | European Commission FP7 - Fatty Liver Inhibition of Progression (FLIP) European Fatty Liver CRN | 5.9 million euros |
| July 2009 | Wellcome Trust Programme Grant - Innate immunity and liver fibrosis (Co-PI with Michael Karin and Derek Mann | £690,415 |
| Jan 2015 | NHMRC – The role of TRPM2 channels in oxidative stress induced liver damage | $558,433 |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2016 - 2020 | Principal Supervisor | Endoscopy-Focused Primary, Secondary and Tertiary Prevention of Colorectal Cancer | Doctor of Philosophy under a Jointly-awarded Degree Agreement with | Doctorate | Full Time | Dr Leonardo Zorron Cheng Tao Pu |
| 2016 - 2021 | Co-Supervisor | The Roles of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis | Doctor of Philosophy under a Jointly-awarded Degree Agreement with | Doctorate | Full Time | Mr Hiroki Kobayashi |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2015 - ongoing | Member | Australian Academy of Health and Medical Sciences | Australia |
| 1991 - ongoing | Member | Member of the Institute of Biologists | - |
| 1988 - ongoing | Member | Membership of Royal College of Pathologists | United Kingdom |
Connect With Me
External Profiles
